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ABSTRACT OF DISSERTATION

NONINVASIVE MULTIMODAL DIFFUSE OPTICAL IMAGING
OF VULNERABLE TISSUE HEMODYNAMICS
Measurement of tissue hemodynamics provides vital information for the
assessment of tissue viability. This thesis reports three noninvasive near-infrared diffuse
optical systems for spectroscopic measurements and tomographic imaging of tissue
hemodynamics in vulnerable tissues with the goal of disease diagnosis and treatment
monitoring. A hybrid near-infrared spectroscopy/diffuse correlation spectroscopy
(NIRS/DCS) instrument with a contact fiber-optic probe was developed and utilized for
simultaneous and continuous monitoring of blood flow (BF), blood oxygenation, and
oxidative metabolism in exercising gastrocnemius. Results measured by the hybrid
NIRS/DCS instrument in 37 subjects (mean age: 67 ± 6) indicated that vitamin D
supplement plus aerobic training improved muscle metabolic function in older
population. To reduce the interference and potential infection risk on vulnerable tissues
caused by the contact measurement, a noncontact diffuse correlation
spectroscopy/tomography (ncDCS/ncDCT) system was then developed. The
ncDCS/ncDCT system employed optical lenses to project limited numbers of sources and
detectors on the tissue surface. A motor-driven noncontact probe scanned over a region of
interest to collect boundary data for three dimensional (3D) tomographic imaging of
blood flow distribution. The ncDCS was tested for BF measurements in mastectomy skin
flaps. Nineteen (19) patients underwent mastectomy and implant-based breast
reconstruction were measured before and immediately after mastectomy. The BF index
after mastectomy in each patient was normalized to its baseline value before surgery to
get relative BF (rBF). Since rBF values in the patients with necrosis (n = 4) were
significantly lower than those without necrosis (n = 15), rBF levels can be used to predict
mastectomy skin flap necrosis. The ncDCT was tested for 3D imaging of BF distributions
in chronic wounds of 5 patients. Spatial variations in BF contrasts over the wounded
tissues were observed, indicating the capability of ncDCT in detecting tissue
hemodynamic heterogeneities. To improve temporal/spatial resolution and avoid motion
artifacts due to a long mechanical scanning of ncDCT, an electron-multiplying chargecoupled device based noncontact speckle contrast diffuse correlation tomography
(scDCT) was developed. Validation of scDCT was done by imaging both high and low
BF contrasts in tissue-like phantoms and human forearms. In a wound imaging study

using scDCT, significant lower BF values were observed in the burned areas/volumes
compared to surrounding normal tissues in two patients with burn. One limitation in this
study was the potential influence of other unknown tissue optical properties such as tissue
absorption coefficient (µa) on BF measurements. A new algorithm was then developed to
extract both µa and BF using light intensities and speckle contrasts measured by scDCT at
multiple source-detector distances. The new algorithm was validated using tissue-like
liquid phantoms with varied values of µa and BF index. In-vivo validation and
application of the innovative scDCT technique with the new algorithm is the subject of
future work.
KEYWORDS: Hybrid Near Infrared Spectroscopy/ Diffuse Correlation Spectroscopy
(hybrid NIRS/DCS), Speckle Contrast Diffuse Correlation Tomography
(scDCT), Noncontact Diffuse Correlation Tomography (ncDCT), Muscle,
Flap, Wound
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CHAPTER 1. STUDY BACKGROUND AND IMPORTANCE

1.1

Hemodynamic assessment of vulnerable tissues
Blood flow (BF) facilitates the delivery of nutrients and oxygen to tissues and the

removal of metabolic byproducts from tissues. BF and its response to physiological
changes indicate underlying tissue microenvironment conditions. It is equally important
to understand tissue oxygenation since assessment of tissue oxygenation provides
important information about the regulation of tissue oxygen delivery. In situations where
oxygen delivery is insufficient to meet the demand, hypoxia will result. Many diseases in
biological tissues may be detected by functional imaging of tissue hemodynamics (i.e.,
blood flow and oxygenation) prior to observable or palpable structural changes. Thus,
monitoring of tissue BF and oxygenation provides critical information to medical
professionals for the diagnosis and treatment monitoring of various diseases.
Hemodynamic assessment also serves in animal studies to study pathology of diseases
and to validate new medications.
One of the most prevalent objects in hemodynamic study is to characterize the
hemodynamics in vulnerable tissues for diagnosis and treatment monitoring.
Specifically, hemodynamic assessment is important for monitoring of vulnerable tissues
such as wounds or injuries. Monitoring of hemodynamics in wounds (e.g., burn wounds,
traumatic injuries) provides essential information for determining the necessity and area
of wound excision and skin grafting to ensure successful surgical outcomes [1]. Notably,
chronic wounds may never heal or take years to heal, thus resulting in poor quality of life
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[2]. Individuals with peripheral arterial disease (PAD), diabetes, and paralysis have the
highest risk of developing chronic wounds [3]. Pressure ulcer has high incident rate in
patients with spinal cord injury and may lead to pain, infection and sepsis [4]. Prolonged
pressure that applied to the tissue reducing blood flow and oxygenation supply, together
with other risk factors including presents of moisture, limited mobility, poor nutrition
and so on, leads to ulcer and prevents the ulcer from healing [4, 5].
Flap surgery is a common approach for tissue reconstruction. The flap is
vulnerable and prone to tissue necrosis, which is one the most common complications
after the surgery [6, 7]. Flap necrosis ensues when the blood supply to the flap is
insufficient to meet metabolic needs. Knowledge of flap blood perfusion and variation
during surgery may enable the surgeon to predict necrosis and failure of flaps. For
example, in this dissertation work, BF in mastectomy skin flap was measured
intraoperatively

for

patients

undergo

mastectomy

and

implant-based

breast

reconstruction immediately after mastectomy. The results suggested that the decrease in
BF from pre- to post- operation was highly correlated with the incidence of flap necrosis,
which demonstrated the potential of intraoperative BF assessment for necrosis
prediction.
In many applications, for example in the assessment of intact muscles, contact
measurement with a probe placed on tissue surface is doable without unforeseen risks.
Contact measurement ensures better data quality for measurements in exercising
muscles, which are prevalently used in studying muscle hemodynamics. However, for
many other types of vulnerable tissues, such as open wounds and surgery incisions,
noncontact measurements are preferred over contact measurements, where infection risk
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and pain induced potentially by applying contact measurements are of great concerns.
Moreover, the contact pressure applied to tissue surface may result in tissue deformation
and alter the tissue hemodynamics, and consequently leading to inaccurate measurement
results. Another benefit of noncontact measurement is that it complies better with sterile
protocols in operating room for those intraoperative measurements.
In contrast to spectroscopic measurements, tomographic imaging of vulnerable
tissue hemodynamics is also desired, as it provides valuable information for determining
the locations and areas of ischemic/hypoxic tissues. For example, imaging of skin flaps
may predict the risky area of tissue necrosis. Hemodynamic imaging of wound and
surrounding tissues facilitates the evaluation of wound healing progress and determines
the treatment strategy such as the necessity and scope of debridement.

1.2

Technologies for the assessment of tissue hemodynamics
A wide range of technologies have been developed to measure tissue BF. Doppler

ultrasound is one of the most commonly used noninvasive techniques [8]. It performs
well in assessing large vessel blood flow; but deep tissue wounds are more related to
impairments in microcirculation. Techniques for microvascular perfusion measurement
include optical coherence tomography [9], photoacoustic tomography [10], optical micro
angiography [11] and skin perfusion pressure measurement [12]. Most of these
techniques provide tissue perfusion information at skin level. Fluorescence angiography
for tissue surface perfusion measurement is invasive and involves intravenous dye
injection [13-15]. The measurement is transient and does not allow for continuous
3

monitoring. It has been applied in flap necrosis prediction and has been reported to over
or under predict the risk of necrosis [15].
Various types of techniques have been developed for tissue oxygenation
assessment. Hyperspectral image detects tissue oxygenation at the skin level [16].
Oxygen microelectrode can measure cellular oxygen level in a single cell although this
method is invasive [17]. Transcutaneous oxygen measurement also measures tissue
oxygenation, but it involves in complicated interaction between different tissue layers
[18].
Larger imaging modalities such as positron emission tomography (PET) and
magnetic resonance imaging (MRI) have the capacity of assessing both tissue
BF/oxygenation and metabolism [19, 20]. These imaging technologies are expensive
with large instruments. They require confinement to measurement tubes and thus limit
the flexibility for muscle function characterization during exercising. In addition, PET
involves radioactive elements, which is harmful to subjects.

1.3

Diffuse optical technologies for hemodynamic assessment of vulnerable tissues
Diffuse optical technologies using near-infrared light (NIR, 650-950 nm) have

become popular over decades because of their noninvasiveness, safety, sensitivity to
relatively deep tissues (up to several centimeters), and relatively lower cost in contrast to
other large imaging instruments. These techniques are particularly useful for bedside and
longitudinal monitoring of deep tissue hemodynamics. A variety of diffuse optical
technologies have been developed for tissue hemodynamic assessment, including NIR
4

spectroscopy (NIRS) and diffuse optical tomography (DOT) for tissue oxygenation
measurements [21-23] and diffuse correlation spectroscopy and tomography (DCS/DCT)
for tissue BF measurements [24-28].
NIRS/DOT for tissue oxygenation measurements. NIRS provides a
noninvasive, low-cost, rapid way for quantification of tissue optical properties, which are
characterized by absorption coefficient µa (cm-1) and reduced scattering coefficient µs’
(cm-1) [29-31]. The transportation of NIR light in biological tissues is dominated by
scattering rather than absorption (µs’ >> µa) and therefore can be treated as a diffusive
process. The absorption spectra of NIR light in biological tissue are shown in Figure 1.1.
Major tissue chromospheres to absorb NIR light include water (H2O), oxy-hemoglobin
(HbO2), and deoxy-hemoglobin (Hb). Because of the relatively low absorption in
biological tissues to NIR light (650 to 950 nm), NIRS can probe deep tissues (up to
several centimeters). Since NIRS is sensitive to hemoglobin concentration variations in
microvasculature, it enables tissue blood oxygenation detection, including oxyhemoglobin concentration ([HbO2]), deoxy-hemoglobin concentration ([Hb]), total
hemoglobin concentration (THC), and blood oxygenation saturation (StO2).
For tomographic imaging with NIRS (i.e., DOT), boundary data measured from
large numbers of source and detector pairs are used to cover a target tissue volume.
Three-dimensional images of tissue optical properties and oxygenation can be
reconstructed from these measured boundary data with DOT principles. DOT has been
used over decades for tissue oxygenation imaging [21, 22].

5

NIR
window

Figure 1.1 Absorption spectra of hemoglobin and water.
Tissue absorption coefficients (µa) of the three major absorbers in biological tissues
(HbO2, Hb and water) are shown as function of wavelengths. Within the NIR window
(650 to 900 nm), all three absorbers have relatively low absorptions thus enabling NIR
light to penetrate deep into tissues. HbO2: oxy-hemoglobin, Hb: deoxy-hemoglobin.

DCS/DCT for tissue blood flow measurements. A dynamic NIR technique,
namely diffuse correlation spectroscopy (DCS), has been developed for blood flow
measurement in deep tissue [24-28]. Similar to NIRS, DCS uses NIR light to probe deep
tissues. However, while NIRS only requires laser source with no specific requirement on
coherence length, DCS uses a long coherence (coherence length > 5 meter) continuouswave (CW) laser as the light source and high sensitivity single-photon-counting
avalanche photodetector (APD) as the detector. DCS detects temporal light intensity
fluctuations resulting from the interactions between photons and red blood cells in
microvasculature at a single speckle area on the tissue surface using a single-mode fiber
that transmits light only directly down the fiber connected to the APD. Through
quantifying the time scale of light intensity fluctuation, DCS extracts blood flow index
(BFI) that is related to the motion of red blood cells. Relative changes in blood flow
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(rBF) are subsequently determined by normalizing flow data to its baseline level prior to
the physiological change. DCS has been extensively validated against other techniques in
various tissues, including Doppler ultrasound in tumors [32], Xenon-CT in traumatic
brains, and arterial-spin labeled MRI (ASL-MRI) in human brains and muscles [24, 33,
34].
Similar to the extension from NIRS to DOT, DCS has been extended to DCT for
three dimensional (3D) imaging of BF distributions using boundary data measured from
multiple source-detector (S-D) pairs on the tissue surface. DCT has been applied for
preclinical applications in small animal models [22, 35, 36].

1.4

Development and application of innovative diffuse optical technologies for
hemodynamic assessment of vulnerable tissues
Conventional NIRS/DOT and DCS/DCT have technical limitations for assessing

vulnerable tissues in different applications, which are described below. To overcome
these limitations, I have optimized three innovative NIR diffuse optical systems for
spectroscopic measurements and tomographic imaging of tissue hemodynamics in
vulnerable tissues with the goal of disease diagnosis and treatment monitoring. These
systems include a hybrid NIRS/DCS, a noncontact DCS/DCT (ncDCS/ncDCT), and a
speckle contrast DCT (scDCT).
Hybrid NIRS/DCS for hemodynamic characterization of exercising muscles
in older adults with Vitamin D (vitD) insufficiency (Chapter 2). The conventional
NIRS or DCS alone is not capable of continuous monitoring of tissue oxidative (i.e.,
7

oxygen consumption rate (VO2)) which provides important information for the
evaluation of muscle metabolic function. One reason for this is that DCS is sensitive to
the motion of muscle fibers and could get motion artifacts in BF measurements during
exercise [37]; the other is that DCS can accurately measure the change in BF relative to a
baseline value, but it is not capable of absolute BF value quantification.
In this study, we combined a commercial NIRS device with a custom-made 4
channel DCS (hybrid NIRS/DCS) for simultaneous measurements of BF, blood
oxygenation, and oxidative metabolism of exercising calf muscles in older adults with
VitD insufficiency. A contact fiber-optic probe was designed for NIRS/DCS data
acquisition from the same region of measured tissues. An innovative gating algorithm
was developed to minimize motion artifacts during exercise [26-28]. Occlusive
calibration protocols were developed for quantification of absolute VO2 and BF values
[26-28]. Using the optimized NIRS/DCS technique, I studied the relationships among
vitD repletion, aerobic exercise, and muscle metabolic function in an older population
with vitD insufficiency [38].
ncDCS/ncDCT for hemodynamic imaging of mastectomy skin flaps and
chronic wounds (Chapter 3). Conventional NIRS and DCS have been used for
noninvasive monitoring of oxygenation and blood flow in deep tissues with fiber-optic
probes that gently contact the skin surface. However, measurements of tissue
hemodynamics using contact probes are not appropriate for vulnerable tissues, such as
surgery site and wound tissues. Contact measurement would increase the risk of infection
and alter the tissue hemodynamic properties by applying the contact probe and thus lead
to inaccurate measurement results.
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To reduce the interference and potential infection risk on vulnerable tissues
caused by the contact measurement, we developed an ncDCS/ncDCT system with optical
lenses to project sources and detectors on the tissue surface [39-42]. The S-D pairs were
arranged in a linear array. The motor-driven noncontact probe scanned linearly over a
selected region of interest (ROI) to collect boundary data for 3D tomographic imaging. A
finite element method (FEM) based reconstruction algorithm was developed for 3D
reconstruction of BF distributions from these boundary measurements [39-41].
I have used the ncDCS/ncDCT system to measure BF distribution in mastectomy
skin flaps for prediction of skin flap necrosis [43]. An intraoperative protocol for flap BF
measurement was designed and implemented in 19 patients who underwent mastectomy
and implant-based breast reconstruction. These patients were measured before and
immediately after mastectomy, and after breast reconstruction. I have also applied the
ncDCS/ncDCT system for 3D imaging of BF distributions in 5 patients with chronic
wounds.
scDCT for 3D imaging of burn wounds (Chapter 4). The ncDCS/ncDCT
system enabled noncontact spectroscopic and tomographic measurements of deep tissue
BF. However, it has poor temporal and spatial resolution due to the time-consuming
mechanical scanning. Each scanning may take up to more than ten minutes, which is
prone to motion artifacts. With limited sources and detectors, its spatial resolution was
poor. The ncDCS/ncDCT system used expensive APDs as detectors, which increase the
instrument size and cost.
To overcome these limitations, we developed a camera-based scDCT system [4446]. A galvo mirror was used to project point source laser light onto the measured tissue

9

surface. The diffused light speckle pattern was detected by a camera through optical lens
system. The BF information was extracted from the speckle contrast measured by the
camera. The scDCT enabled rapid data acquisition with high spatial resolution and
without mechanical scanning. The optical lens system enabled flexible selection of
different sizes of ROI for different applications. I used the innovative scDCT system to
image patients with burned tissues [47].
One limitation of the scDCT system is the potential influence of unknown tissue
optical properties such as µa on BFI quantification. Therefore, I developed a new
algorithm to extract both µa and BFI using light intensities and speckle contrasts
measured by scDCT at multiple S-D distances. I also designed and conducted tissue-like
phantom tests to validate this innovative algorithm.
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CHAPTER 2. HYBRID NEAR-INFRARED SPECTROSCOPY/DIFFUSE CORRELATION
SPECTROSCOPY (NIRS/DCS) FOR ASSESSMENT OF EXERCISING MUSCLE
HEMODYNAMICS IN OLDER ADULTS WITH VITAMIN D (VITD) INSUFFICIENCY

2.1

Introduction
Characterization of metabolic function in skeletal muscle has important

applications in exercise and sports medicine and provides key information for
understanding many diseases affecting skeletal muscle, such as peripheral vascular
disease, fibromyalgia and heart failure [48-54]. Understanding of muscle metabolic
function in older adults is fundamental for understanding the pathology of most agerelated co-morbidities and has the potential to combat muscle function loss and to
improve life quality.
Since differences in muscle function between healthy population and population
with muscle dysfunction are not always apparent at rest, it is important to study muscle
hemodynamic and metabolic changes in response to stimuli such as rhythmic exercise
[49, 52, 54-56]. The ability to noninvasively quantify local muscle hemodynamics during
exercise should provide critical information for muscle metabolic function evaluation,
and has great potential for improving disease diagnosis and treatment assessment.
Vitamin D (VitD) and exercise have positive effects on muscle health. Emerging data
suggest that combining these treatments can alter muscle lipid distribution and
mitochondrial capacity [57, 58]. This combination may preserve skeletal muscle function
in aging [58, 59]. Therefore, assessment of muscle hemodynamics during exercise can be
employed to evaluate muscle performance for older population who receive vitD

repletion and/or aerobic training in order to study the relationship between vitD
repletion, aerobic training and skeletal muscle metabolic function.
Various techniques have been used in assessment of skeletal muscle blood flow
(BF) during exercise in previous studies. Doppler ultrasound has been used for this
purpose but it is limited to large vessel BF assessment. Microvascular BF evaluation
techniques include laser Doppler flowmetry (LDF) [60, 61], skin perfusion pressure [12],
and optical coherence tomography [62]; however, these techniques are limited to surface
BF assessment at skin level. Positron emission tomography (PET) [63] and arterial-spinlabeled magnetic resonance imaging (ASL-MRI) [64] have made deep tissues
microvascular BF monitoring possible, but these imaging modalities require large and
expensive instrumentation that limits their use in exercise monitoring.
Oxygen consumption (VO2) in skeletal muscle has also been quantified by several
technologies. Muscle VO2 can be measured invasively using the Fick principle that
calculates VO2 as the arteriovenous oxygen concentration difference times the cardiac
output with blood sampling via catheter; however it does not accurately reflect the VO2
level in local microvasculature because the blood samples are taken from major vessels
connected to several muscle groups [65]. Spirometry measures whole body VO2
noninvasively but it does not specify local tissue contribution [66]. Local muscle VO2
has been quantified noninvasively by phosphorus magnetic resonance spectroscopy (PMRS) but requires large and expensive equipment with limited sensitivity, thus limiting
its application in exercise monitoring [67].
Near infrared (NIR) diffuse optical methods for tissue hemodynamics
quantification have gained popularity in recent years. In previous studies, Near infrared
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spectroscopy (NIRS) has been applied in investigation of tissue oxygenation changes in
skeletal muscles during different types of exercise. Another NIR optical technology,
diffuse correlation spectroscopy (DCS), has been developed for non-invasive
measurement of the relative change of BF (rBF) in deep tissues [26-28, 32, 34, 68-71],
including skeletal muscles [26-28, 34, 70]. DCS measurements of tissue BF have been
validated by other standards, including Doppler ultrasound [56], Xenon-CT [24], and
ASL-MRI [33].
Our laboratory has developed a hybrid optical device combining frequency
domain (FD) NIRS and DCS technologies for simultaneous measurements of oxy and
de-oxy hemoglobin concentrations ([HbO2], [Hb]), total hemoglobin concentration
(THC), tissue blood oxygen saturation (StO2), and rBF [72]. Simultaneous measurements
of rBF and StO2 enable the calculation of relative change in oxygen consumption (rVO2)
[56]. Only recently, an occlusive calibration has been applied by our lab to allow hybrid
NIRS/DCS to simultaneously and continuously measure absolute values of BF and VO2
in skeletal muscle [26, 28]. DCS is highly sensitive to muscle fiber motion and causes
overestimation of BF during exercise, which prevented it from use in exercise
monitoring. Recently, an innovative gating algorithm has been developed and applied in
hybrid NIRS/DCS for exercising muscle monitoring to collect BF data only at time
points when muscle fiber motion is minimal [26, 28, 37]. The application of the gating
algorithm significantly improves the accuracy of BF measurements using DCS, and thus
improved the accuracy in VO2 quantification during exercise using hybrid NIRS/DCS.
The hybrid NIRS/DCS system has been used in arm muscle measurements during
exercise in previous studies [26, 27]. However, our particular interests are in the leg
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muscles because lower limb is more likely influenced by diseases, such as peripheral
arterial disease (PAD) and muscle metabolic dysfunction [73, 74]. Therefore, we applied
the hybrid NIRS/DCS system for the hemodynamics monitoring during calf muscle
exercise [28]. I have validated the hybrid NIRS/DCS system for calf muscle monitoring
first in young healthy subjects and established the methods for the characterization of
hemodynamic changes during exercise and in post-exercise recovery [28].
In this chapter, I report the methods and applications of our innovative hybrid
NIRS/DCS instrument for quantification of calf muscle hemodynamics during exercise
in older adults that are given vitD repletion and/or aerobic training to determine the
effects of vitD repletion and aerobic training on hemodynamic and metabolic functions
of skeletal muscles.

2.2
2.2.1

Methods
NIRS for tissue oxygenation
NIRS theory. The NIR window (650 to 900 nm) has made the application of

diffuse optical measurements possible for biological tissues. The major chromophores in
biological tissue are water and hemoglobin (oxyhemoglobin and deoxyhemoglobin).
Within the NIR window, the absorption coefficient (µa) of water and hemoglobin are
relatively low, allowing photons to penetrate deeply into tissue to up to several
centimeters. The photon transportation in biological tissue can be treated as a diffusive
process because scattering is the dominant event [75, 76]. The scattering coefficient (μ′𝑠 )
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is typically much larger (10 folds) than µa, therefore a photon may have been scattered
multiple times before it is absorbed and a random walk pattern would be observed.
The diffusive process of photon propagation in biological tissue can be described
by the photon diffusion equation [76, 77]. Specifically, the measured photon fluence rate,
Φ (𝒓,t) [W𝑎𝑡𝑡 ∙ 𝑐𝑚-2 ], obeys the photon diffusion equation written in frequency domain
as follows [76, 78]:
∇ ∙ (D(𝒓) ∇Φ(𝒓,𝑡)) – 𝜐 𝜇a (𝒓) Φ(𝒓,𝑡) + 𝜐 𝑆(𝒓,𝑡) =

∂Φ(𝒓,𝑡)
∂𝑡

(2.1)

Where, 𝒓 is the position vector, t [s] is time and 𝜐 [cm ∙ 𝑠 −1] is the speed of light
in the medium. 𝜇a(𝒓) [𝑐𝑚-1 ] is the absorption coefficient, 𝜇s′ (𝒓) [𝑐𝑚−1 ] is the reduced
scattering coefficient, and 𝐷(𝒓) ≡ 𝑣/3(𝜇𝑎 (𝒓) + 𝜇𝑠′(𝒓)) ≈ 𝑣/3µ𝑠′ (𝒓) [𝑐𝑚2 ∙ 𝑠-1 ] is the
photon diffusion coefficient. S(𝒓,𝑡) [𝑊𝑎𝑡𝑡 ∙ 𝑐𝑚−2 ] is the isotropic source term which
quantifies the number of photons emitted at position 𝒓 and time t per unit volume per
unit time.
The right hand side (

∂Φ(𝒓,𝑡)
∂𝑡

) describes the rate of the change of photon flunece

within the sampled volume. It equals the number of photons scattered into the volume
per unit time from its surroundings (∇ ∙ (D(𝒓) ∇Φ(𝒓,𝑡))), minus the number of photons
absorbed per unit time within the volume (𝜐 𝜇a (𝒓) Φ(𝒓,𝑡)), plus the number of photons
emitted per unit time from any sources in the volume (𝜐 𝑆(𝒓,𝑡)). This diffusion
approximation is valid when the following two premises are met: 𝜇𝑎 ≪ 𝜇𝑠′; the distance
between source and detector is much greater than the random walk step length (~ 1mm in
biological tissue) [78].
When using point source, which can be mathematically described as S(𝒓,𝑡) =
𝑆0𝛿(𝒓 − 𝒓𝑠)exp(−i𝜔t), where 𝑆0 is a constant, 𝜔 is the modulation frequency of sinusoidal
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oscillation of the source. and 𝑟𝑠 is the source location, Equation 2.1 can be simplified to
[79]:
𝐷(r)

∇ ∙ ((

υ

) ∇Φ(𝒓)) − (𝜇𝑎 (𝒓) +

iω
υ

) Φ(𝒓) = 𝑆0𝛿(𝒓 − 𝒓𝑠 )

(2.2)

Where Φ(𝒓,𝑡) = Φ(𝒓)exp(−i𝜔t).
The analytical solution of Equation 2.2 in semi-infinite geometry is [80]:
v𝑆

0
Φ(ρ) = 4πD
(

exp(−K𝑟1 )
𝑟1

−

exp(−K𝑟2 )
𝑟2

)

(2.3)

Where 𝐾 2 = 3𝜇𝑠 ′ (− 𝑖𝜔/𝑣 + 𝜇𝑎) , 𝑟1 = √ρ2 + 𝑧02 and 𝑟2 = √ρ2 + (𝑧0 + 2𝑧𝑏 )2 ,
ρ is the source-detector (S-D) distance, 𝑧𝑏 is the distance above the tissue surface where
the fluence rate extrapolates to zero and 𝑧0 is the effective depth of the source, 𝑧0 = 1/𝜇𝑠 ′
and 𝑧𝑏 =

2 1+ 𝑅𝑒𝑓𝑓
3μ′𝑠 1− 𝑅𝑒𝑓𝑓

, 𝑅𝑒𝑓𝑓 = −1.44𝑛

−2

+ 0.71𝑛

−1

+ 0.668 + 0.064𝑛, 𝑛 ≈ 1.33(for

biological tissues). The 𝑅𝑒𝑓𝑓 term accounts for the mismatch between the medium and
the air indices of refraction with 𝑛 being the ratio between them.
To apply NIRS measurements for tissue absorption and scattering, photodetectors
are typically used to detect the diffused light at known distances (few millimeters to
centimeters) from point sources. Figure 2.1 shows a simple measurement setup with one
pair of source and detector in reflection geometry. Light injected into the tissue from
source can be detected by the detector placed at a distance ρ from the source location.
The sensitive region of diffuse light is usually described as a “banana pattern” with the
penetration depth of ~ρ/2 [78, 81].
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Figure 2.1 Photon transportation in biological tissues.
The source and detector fibers are placed on the tissue surface separated by a distance ρ.
Grey and red dots represent tissue absorbers and scatterers respectively. Multiple
scattering happen along a single photon path. The green arrows represent the moving
directions of scatterers. The solid and dashed blue lines indicate potential paths of the
detected photons. The dashed black lines indicate the potential paths of the photons
absorbed before reaching to detector. The banana shape area indicates the average path of
the detected photons emitted from the source location.

Multi-distance measurements of the phase and the amplitude of the photon
fluence rate Φ(𝒓,𝑡) with FD-NIRS system enable the extraction of optical properties (𝜇𝑠′
and 𝜇𝑎) of the measured tissue by fitting the analytical solution (Equation 2.3) with the
measured fluence rate [82-84]. In the NIR band, deoxyhemoglobin (Hb) and
oxyhemoglobin (HbO2) have different absorption spectra (Figure 1.1) [85], therefore the
concentrations of [Hb] and [HbO2] can be calculated from known 𝜇𝑎 at two (or more)
wavelengths [28, 82, 86]. The measured 𝜇𝑎 (λ) at each wavelength can be decomposed
into the absorption contributions from the major tissue chromophores including Hb,
HbO2 and water (H2O) [23]:
μa(λ) = ɛHb(λ)∙[Hb] + ɛHbo2(λ)∙[HbO2] + 𝑃𝐻2 𝑂 ∙ μ𝑎(𝐻2 𝑂) (λ)
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(2.4)

Here, ɛ is wavelength-dependent extinction coefficient of the major tissue
chromophores. Water absorption is usually considered constant and is thus fixed
according to literature [87, 88]. Therefore, the two unknowns of [Hb] and [HbO2] can be
solved with assessment of μa at minimum two wavelengths.
THC and StO2 can be derived based on [Hb] and [HbO2] consequently as the
following: THC = [Hb] + [HbO2]; StO2 = [HbO2]/THC × 100%.
FD-NIRS instrument. In this study a commercial FD-NIRS (Imagent, Iss Inc.,
IL, USA) was used (Figure 2.2). The machine has two banks of sources (eight laser
diodes at same wavelength for each bank) and one photomultipliers (PMT) detector. The
2 source wavelengths this machine has are 690 nm and 830 nm. The fiber-optic probe is
optically coupled to laser-diode sources through multimode fibers (400 um fiber core).
Sources are distributed at multiple distances (ρ = 2.0, 2.5, 3.0, and 3.5 cm) from the
detector location. A large fiber bundle (2.5 mm in diameter) connected from the detector
location on the probe to the PMT is used to detect the scattered light from the tissue.
Source light at 690 and 830 nm are modulated at 110 MHz and multiplexed so that only
one laser diode in each bank is on at a time. Fluence rate (AC, DC and phase) are
measured and used to calculate 𝜇𝑠′ and 𝜇𝑎 for each wavelength and secondary outcomes
([Hb], [HbO2], etc.).
Typically, the measurement time for each cycle covering all S-D pairs and
wavelengths is 150 ms. Data from several cycles may be averaged to improve signal-tonoise ratio (SNR) upon specific measurement needs.
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Figure 2.2 FD-NIRS device and probe.
(a) Commercial FD-NIRS (Imagent, Iss Inc., IL, USA); (b) Schematic of FD-NIRS; (c)
Probe configuration of Imagent.
FD-NIRS: frequency domain near infrared
spectroscopy.

2.2.2

DCS for tissue blood flow (BF)
DCS theory. Similar to NIRS, DCS also probes deep tissues with NIR light.

Instead of quantifying tissue blood oxygenation from the relatively slow changes in light
intensities due to tissue absorption and scattering changes, DCS monitors the motion of
moving scatterers (majorly red blood cells) in tissue by quantifying the fast temporal
fluctuations in light intensities [36, 78, 89].
The normalized light intensity temporal autocorrelation function is calculated to
characterize the light intensity fluctuations at multiple delay time τ:
𝑔2 (𝒓, 𝜏) = 〈 𝐼 (𝒓,) ∙ (𝒓, + 𝜏)〉/〈𝐼(𝒓,𝑡)〉2

(2.5)

Here, 𝐼 (𝒓,t) is the detected light intensity at position vector 𝒓 (from a source to a
point of detection) and at time 𝑡. The < > denotes a time average. 𝑔2 is calculated from
the detected intensity fluctuations of scattered light. 𝜏 represents the delay time of
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autocorrelation function. 𝑔2 (𝒓, 𝜏) is related to the normalized electric field temporal
autocorrelation function, 𝑔1(𝜏), through the Siegert relationship [90]:
𝑔2 (𝒓, 𝜏) = 1 + 𝛽|𝑔1 (𝒓, 𝜏) |2

(2.6)

Here, 𝛽 is a coherence factor depending mainly on the laser coherence and
detection optics. 𝛽 can be determined experimentally from measured 𝑔2 (𝒓, 𝜏) via 𝛽 = 𝑔2
(𝒓, 0) − 1.
The unnormalized electric field temporal autocorrelation 𝐺1 is defined by
𝐺1 (𝒓, 𝜏) = 𝑔1 (𝒓, 𝜏) ∙ 𝐺1 (𝒓, 0) = 𝑔1 (𝒓, 𝜏) ∙ I (𝒓, 0)

(2.7)

The motions contributed by moving scatterers in biological tissue (red blood
cells) result in the exponential decay of G1. The propagation of G1 in biological tissues
can be described by the correlation diffusion equation in homogeneous medium for
continuous-wave (CW) light source [36, 78, 89]:
∇ ((

𝐷(r)
υ

1

) ∇𝐺1 (𝒓, 𝜏)) − (𝜇𝑎 + 3𝜇𝑠′ 𝑘02 𝛼〈∆𝑟 2 (𝜏)〉) 𝐺1 (𝒓, 𝜏) = − 𝑆0 𝛿(𝒓)

(2.8)

Here D(𝒓) ≈ 𝑣/3µ𝑠′, 𝑣 is the light speed in the medium, 𝑆0 𝛿(𝒓) is the CW source
term, 𝑆0 is a constant. 𝑘0 = 2𝜋𝑛⁄𝜆 is the wave number of the source light in biological
tissue, n = 1.33, 𝜆 is the source light wavelength. 〈∆𝑟2 (𝜏)〉 is the mean-square
displacement of moving scatterers at delay time τ. To adapt the correlation diffusion
equation for the use in biological tissues, a unitless factor α (ranging from 0 to 1) is
introduced here to represent the ratio of light scattering events resulted from “moving”
scatterers (e.g., red blood cells) to the total scatterers, since some of the scatterers in
tissue are “static” (e.g., organelles, mitochondria, and nuclei). The factor α is included as
a pre-fix to 〈∆𝑟

2

(𝜏)〉 (i.e., α〈∆𝑟

2

(𝜏)〉) to indicate the mean square displacement of
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“moving” scatterers in biological tissues. In a semi-infinite homogeneous medium,
analytical solution of 𝐺1 (𝒓, 𝜏) are [78]:
v𝑆

0
𝐺1 (𝒓, 𝜏) = 4πD
(

𝑒 −𝐾(𝜏)𝑟1
𝑟1

−

𝑒 −𝐾(𝜏)𝑟2
𝑟2

)

(2.9)

Consequently, combing with Equation 2.7, the analytical expression for 𝑔1 (𝒓, 𝜏)
can be derived as:
𝑔1 (𝒓, 𝜏) =

G1 (𝒓,τ)
G1 (𝒓,0)

=(

𝑒 −𝐾(𝜏)𝑟1
𝑟1

−

𝑒 −𝐾(𝜏)𝑟2
𝑟2

)/(

𝑒 −𝐾(0)𝑟1
𝑟1

−

𝑒 −𝐾(0)𝑟2
𝑟2

)

(2.10)

where 𝐾 2 (𝜏) = 3𝜇𝑠′𝜇𝑎 + 𝜇𝑠′2 𝑘02𝛼〈∆𝑟2 (𝜏)〉, is an effective “absorption” for the
attenuation of G1 as it transports through the tissue; while 𝑟1, 𝑟2 and 𝒓 are the same as in
Equation 2.3.
For diffusive motion, 𝛼〈∆𝑟2(𝜏)〉 = 6𝛼DB 𝜏, where DB is the effective Brownian
diffusion coefficient of tissue scatterers [91]. The combined term, 𝛼𝐷B, is referred as the
blood flow index (BFI) in tissues and its relative change is commonly used to calculate
the relative change of blood flow (rBF) compared with the baseline/resting BFI.
By introducing the BFI term 𝛼DB, it is easy to tell that the analytical solution of
𝑔1(𝒓, 𝜏) is a function of 𝛼DB and tissue optical properties (e.g., 𝜇𝑠′ and 𝜇𝑎). Tissue optical
properties can be measured using NIRS or assumed from literature, then 𝑔1(𝒓, 𝜏) is solely
determined by 𝛼DB. Meanwhile, the measured 𝑔1(𝒓, 𝜏) can be converted from the
measured 𝑔2(𝒓, 𝜏) using the Siegert Relation (Equation 2.6) [90].Therefore, 𝛼DB can be
extracted by varying 𝛼DB in the analytical solution of 𝑔1(𝒓, 𝜏) and fitting it to the
measured 𝑔1(𝒓, 𝜏) [25-28, 82].
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DCS instrument. Figure 2.3a shows a 4-channel DCS device used in this study.
It is consisted of a CW long coherence laser (coherence length > 5 m) at 830 nm (100
mw, CrystaLaser Inc., NV, USA), 4 single-photon-counting avalanche photodiodes
(APDs) (e.g., Perkin Elmer Inc., Canada), and an autocorrelator board (Correlator.com,
NJ, USA).

Figure 2.3 DCS device and probe.
(a) A 4-channel DCS device; (b) Schematic of DCS; (c) DCS probe. DCS: diffuse
correlation spectroscopy.

The laser and APDs are connected to tissue surface through optical fibers. A
fiber-optic probe is usually made with foam pad to confine source and detector fibers
(Figure 2.3c). The S-D separation along the tissue surface is selected according to the
specific applications. Same as NIRS, the penetration depth is typically half of the
distance between source and detector.
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During a measurement, the laser diode shines the NIR light through a source fiber
(multi-mode fiber, diameter = 200 µm) into the tissue (Figure 2.3b). The temporal light
intensity variations caused by the moving scatterers in a single speckle area are detected
by detector fiber(s) (single-mode fiber, diameter = 5 µm) connected to the APD(s). The
output of the APD is sent to the autocorrelator board to calculate the normalized light
intensity temporal autocorrelation function (g2). g2 at each delay time (𝜏) is saved to data
log and used to extract αDB in post processing (see data processing diagram in Figure
2.3b).

2.2.3

Hybrid NIRS/DCS
In order to measure blood flow and oxygenation simultaneously, our lab built the

hybrid NIRS/DCS. Figure 2.4 shows the picture and diagram of the hybrid NIRS/DCS
instrument [26-28, 71]. Computer-controlled TTL signals were used to trigger the
Imagent and DCS devices working sequentially. A 50 ms delay between the transition of
Imagent and DCS measurements was set to avoid the potential interference between the
two devices. The hybrid fiber-optic probe was modified based on the commercial
Imagent probe (Figure 2.5) by housing the DCS source and detector fibers into the
Imagent probe. The optical fibers for the DCS measurement were arranged in the pattern
shown in Figure 2.5 for minimal interference between DCS and NIRS measurements,
and for flexible selection of S-D separation for blood flow measurement (1.5 cm to 2.5
cm). Acquisition times for NIRS and DCS measurements can also be varied based on the
needs for specific applications.
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In addition to simultaneous measurements of BF and tissue oxygenation, the
hybrid NIRS/DCS allows for calculation of rVO2: rVO2 = (100 - StO2)/(100 - resting
StO2) × rBF, which is a critical parameter for assessment of tissue viability.

Figure 2.4 hybrid NIRS/DCS device.
The hybrid NIRS/DCS consists of a commercial FD-NIRS (Imagent, right) and a 4channel DCS flowmeter (left). The Imagent and DCS work alternatively and
communicate with each other through TTL signals. NIRS: near infrared spectroscopy,
DCS: diffuse correlation spectroscopy, FD: frequency domain.
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Figure 2.5 Fiber-optic probe for hybrid NIRS/DCS device.
The hybrid probe is made based on the commercial Imagent probe by inserting DCS
source and detector fibers into the probe. Several slots have been created for flexible
selection of source-detector separation(s) for DCS measurement. NIRS: near infrared
spectroscopy, DCS: diffuse correlation spectroscopy.

2.2.4

Occlusive calibrations for absolute oxygen consumption rate (VO2) and BF
Each subject was placed in sitting position with the right foot secured to a

dynamometer (Primus, BTE, Hanover, MD) foot plate (Figure 2.7). The fiber-optic
probe for NIRS/DCS was attached to the belly of the calf muscle. A pressure/occlusion
cuff (Zimmer ATS 1000, Indiana) was affixed to the thigh of the right leg. The optical
probe was then secured to the medial gastrocnemius. Then a series of occlusion were
completed. The protocol is illustrated in Figure 2.8 (a). A 3-min baseline period was
recorded by the hybrid NIRS/DCS to ensure hemodynamic stability. After the baseline
measurement, three venous occlusions (VO) (50 mm Hg tourniquet pressure for 10 s)
were performed, each with 1 min in between to allow tissue hemodynamics return to
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rest. Upon completion of the three VOs, a single arterial occlusion (AO) (∼250 mmHg)
was performed for 3 min. Subject recovery was monitored following the AO for 5 min.

Figure 2.6 Hybrid NIRS/DCS measurements of exercising gastrocnemius with
occlusive calibrations and gating algorithms.

Baseline absolute BF was obtained by fitting the slope of the THC increase
measured by NIRS during VO (Figure 2.7 (b)) [27, 73]. The three slopes were then
averaged as the absolute BF. Baseline absolute VO2 was calculated by fitting the slope of
the difference between [HbO2] and [Hb] during the first minute of AO (Figure 2.7 (c))
[26, 92].
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Finally, the time-course rBF and rVO2 data were calibrated to absolute BF and
VO2 by multiplying the absolute baseline BF and absolute baseline VO2 obtained
through the VO and AO protocols, respectively.

Figure 2.7 Occlusive calibrations for absolute BF and VO2.
(a) Protocol illustration. (b) THC slope during VO was used to calculate baseline BF. (c)
[HbO2] – [Hb] slope during AO was used to calculate baseline VO2. THC: total
hemoglobin concentration, [HbO2]: oxy-hemoglobin concentration, [Hb]: deoxyhemoglobin concentration, VO: venous occlusion, AO: arterial occlusion,

2.2.5

Gating algorithm
The gating algorithm was designed to reduce the influence of muscle fiber motion

on DCS measurements [27, 28, 37]. The logic of the gating algorithm is illustrated in
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Figure 2.8. The algorithm determines muscle contraction status during plantar flexion
based on an analog voltage output of foot pedal position from dynamometer (blue curve
in Figure 2.8). The analog voltage output decreased with foot/pedal position changes
during plantar flexion and increased back when the foot/pedal was bouncing back to
resting position.

Figure 2.8 Illustration of gating algorithm.
The blue curve represents the signal from dynamometer voltage output, indicating foot
pedal position. Red marks in each cycle illustrate triggers determined by a threshold. The
hybrid NIRS/DCS collects data during muscle relaxation (inside the black square)
between contractions.

Each time the voltage surpasses a threshold when the foot/pedal bounced back
indicating muscle status changing from contracted status (low voltage) to relaxed status
(higher voltage plateau), a trigger signal will be sent to DCS. After a short delay (50 ms)
to allow for residual motion, DCS then begins recording data. After DCS finishes data
collection, NIRS will be triggered to collect data. After a complete frame had been
collected by the hybrid NIRS/DCS, the algorithm waits for the next rising edge in the
position signal to trigger the next data collection sequence. Thus, DCS sampling window
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is constrained to the rest period between each cycle of muscle contraction during
exercise period. In this study, DCS sampling time was about 600 ms, and NIRS sampling
time was about 300 ms, together with some communication time in between, the total
sampling time for each frame of the hybrid NIRS/DCS was around 1 second.

2.2.6

Fatigue gastrocnemius plantar flexion protocol
Subjects were seated on a dynamometer (BTE Primus RS, Maryland) with the

calf exposed for easy placement of the fiber-optic probe of NIRS/DCS (Figure 2.6) [26,
28]. The right foot was placed and secured in the plantar-flexion attachment. Following a
warm up to familiarize the subject with the plantar flexion movement, maximal
voluntary isometric contractions (MVC) were completed to determine the maximum
torque generation. The highest concentric plantar-flexion peak-torque value is recorded
as the final MVC. After MVC test, the fiber-optic probe for NIRS/DCS was attached to
the belly of the calf muscle. Gastrocnemius hemodynamics, including blood flow (BF),
blood oxygen saturation (StO2), and oxygen consumption rate (VO2), were then
continuously monitored before, during and after the fatigue exercise [26, 28]. Three
minutes of resting status data was first taken prior to the start of fatigue exercise. During
the fatigue exercise, subjects were asked to complete 75 repetitions of isotonic concentric
plantar-flexion contractions at maximal voluntary angular velocity with torque set to
35% of MVC. During the exercise, the previously described gating algorithm (Chapter
2.2.5) was used to automatically collect hemodynamic data at an eccentric phase pause
(by reading foot pedal angular position) prior to every plantar-flexion contraction to
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reduce the motion artifact. Foot pedal position and torque were also continuously
recorded during the exercise (Chapter 2.5.1). After completion of the exercise, 15
minutes recovery was recorded.
Gastrocnemius BFI was extracted from DCS data. For this study, S-D separation
for DCS was set at 2.5 cm (Figure 2.5) so that the detected signal would be primarily
from skeletal muscle layer rather than subcutaneous adipose tissue. A 4-in-1 detector
fiber was used that four fiber cores were integrated together on one end and were
plugged at the same location (4 different single speckle areas that were ~ 5 µm apart
from each other) in the probe, while the other end of each fiber were connected to one of
the four APDs. Therefore, in the post processing, a spatial average was used to average
DCS data from the 4 channels at the same time frame to increase the SNR before
extracting 𝛼DB.
StO2 was calculated from NIRS data at multiple separations (2.0–3.5 cm). rBF
was calculated by normalizing BFI at all time frames to the averaged BFI (assigning
100%) during the last 2 min prior to the exercise [28]. Resting StO2 was calculated as an
average of StO2 during the last 2 min prior to exercise. ΔStO2 was calculated as the
increase of StO2 at all measurement times from resting StO2 to minimize the influence of
individual variation in resting StO2 and to enhance the StO2 response induced by the
fatigue exercise. The rVO2 was calculated as rVO2 = (100 - StO2)/(100 - resting StO2) ×
rBF. Recovery half-time (T50) of rVO2 was calculated as the time interval from the end
of exercise to the time that they reached a half-maximal value to characterize postfatigue exercise recovery [27].
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2.2.7

Monitoring of muscle hemodynamics during fatigue gastrocnemius plantar
flexion in older adults with vitD insufficiency

This was a 13-week double blinded placebo, controlled study. The experimental
protocol was approved by the University of Kentucky (UK) Institutional Review Board
(IRB). Subjects in normal weight to class I obese (body mass index = 18.5 to 34.9 kg/m2)
between 60 to 80 year-old and with vitD insufficiency (25(OH)D ≤ 32 ng/mL) were
recruited. Subjects who passed the screening were randomized into one of the 4 group
assignments: vitD repletion + aerobic training (DAT), aerobic training (AT), vitD
repletion alone (D) and control (CTL).
Before (week 0) and after (week 13) the intervention, muscle hemodynamics
during fatigue exercise was measured using the hybrid NIRS/DCS for each subject. The
occlusive calibration was first done to quantify baseline BF and VO2 with the method
introduced in Chapter 2.2.4. Then gastrocnemius hemodynamics during fatigue plantar
flexion protocol (Chapter 2.2.6) was measured. rBF, rVO2, StO2, ΔStO2 and T50 of
rVO2 were calculated as introduced in Chapter 2.2.6.
ANOVA and paired t-tests were used to evaluate the intervention effects. Values
were presented as mean ±standard error of mean (SEM).

2.3

Results
Thirty-seven subjects completed the intervention and participated in both baseline

(week 0) and endpoint (week 13) measurements. Figure 2.9 shows a typical
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hemodynamic responses profile in rBF, rVO2, and StO2 in subjects during fatiguing
exercise.

Figure 2.9 Typical muscle hemodynamic responses to exercise.
Representative profile of (a) blood oxygen saturation (StO2), (b) relative blood flow
(rBF), and (c) relative oxygen consumption rate (rVO2) in a subject throughout the
fatiguing exercise. Solid vertical lines indicate the beginning and the end of fatiguing
exercise. Half recovery time (T50) definition is demonstrated in (c).

At baseline prior to the intervention, there were no differences in blood flow
during the fatiguing exercise protocol between groups; however endpoint comparisons
showed significant group differences (p = 0.04, ANOVA) (Figure 2.10(a)). DAT had
significant higher blood flow during exercise than CTL (p = 0.01) and AT (p = 0.01).
Similar trend were found in rVO2 during exercise. rVO2 during exercise of DAT was
significantly higher at endpoint than CTL (p = 0.007), AT (p = 0.002), and D (p = 0.013,
ANOVA) (Figure 2.10(b)). No significant differences in StO2 were found between
intervention groups during exercise at baseline or endpoint.
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Upon finishing the fatiguing exercise, hemodynamic variables began to return
towards their pre-exercise levels: rVO2 and rBF decreased during recovery, and StO2
increased during recovery. Throughout the 15 minutes of recovery, there were no
significant differences in rBF, rVO2, or StO2 by time or by group (p>0.05,
RMANOVA). To further explore the intervention effects on StO2 we examined shifts in
StO2 from baseline to endpoint for each minute of recovery (minutes 1-15). Within
group comparisons showed that DAT was the only group had significant reduce in
StO2 towards full recovery from baseline to endpoint (Figure 2.11(a)). The observed
DAT group trends became stronger from minutes 1 to 6 in recovery phase. Significance
was attained (p<0.05, paired t-test) at minute seven and continued throughout the rest of
recovery. Statistical differences are represented by an average of StO2 during the final
minute of recovery (Figure 2.11(b)).

Figure 2.10 Hemodynamic responses to 13 weeks of intervention.
(a) Endpoint (week 13) relative blood flow (rBF) during exercise by group (AT: aerobic
training; CTL: control; D: vitamin D; DAT: vitamin D + aerobic training). (b) Endpoint
(week 13) relative oxygen consumption rate (rVO2) during exercise by group. (c)
Recovery half-time (T50) of rVO2 at study baseline (week 0) and endpoint. Bars
represent mean ±SEM.
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Figure 2.11 Muscle blood oxygen saturation responses to 13 weeks of intervention in
post-exercise recovery.
(a) Change in oxygen saturation (ΔStO2) by group at study baseline (week0) and endpoint
(week 13) in post-exercise recovery (AT: aerobic training; CTL: control; D: vitamin D;
DAT: vitamin D + aerobic training). (b) DAT: group average of ΔStO2 at baseline and
endpoint during and post exercise. Bars represent mean ±SEM.

For rVO2 T50, paired t-tests showed a significant decrease in only DAT (-28.7 ±
31.3 seconds, p=0.03) (Figure 2.10(c)). However, there were no differences among
groups in StO2 T50 (p>0.05). Due to rapid change, the recovery half time of blood flow
was not calculated.
Lastly, no significant changes in torque or in absolute BF, absolute VO2 were
observed.

2.4

Discussion and conclusions
We have developed a hybrid NIRS/DCS system for simultaneous and continuous

monitoring of tissue oxygenation and BF. Simultaneous measurements of NIRS and
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DCS enable quantification of skeletal muscle rVO2. The novel occlusive calibration
techniques and the gated dynamometer exercise protocol that have been previously
applied on forearms have been tailored to the lower limb for the first time in this study
[26-28, 93]. Occlusive calibrations make it possible to quantify absolute values of BF
and VO2. We also developed an exercise protocol for lower limb that is comparable in
duration and intensity to other studies and could be done by both healthy subjects and
PAD patients [28]. Innovative gating algorithms significantly reduce motion artifacts and
improve the accuracy of BF measurements during exercise. The removal of these
artifacts means that DCS can produce rapid, continuous examination of microvascular
muscle BF during exercise, which is a unique functionality of the system.
We have successfully applied the hybrid NIRS/DCS for the characterization of
muscle hemodynamics during and post gastrocnemius fatiguing exercise in an older
healthy active population with vitD insufficiency. The DAT intervention had significant
effects on rBF, StO2, and rVO2 T50. We examined shifts in StO2 from study baseline
to end study to better represent StO2 response to exercise. DAT was the only group that
had significant decrease in StO2 during the recovery (min 7-15). A reduction in StO2
indicates an enriched mitochondrial capacity by increasing oxygen extraction to muscles
[27]. DAT was the only group experienced a significant decline in rVO2 T50 over time
(baseline to endpoint), which could be attributed to a beneficial alteration of muscle
oxygen utilization, suggesting improved mitochondrial function. Together, these changes
in hemodynamics and oxygen consumption may be attributed to multiple mechanisms
including improved muscle blood flow and oxygen delivery creating a reduction in
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oxygen debt, improved lipid substrate availability to the mitochondria, and direct
improvements of mitochondrial function [94].
In summary, NIRS/DCS data show increased rVO2 and rBF in response to
fatiguing exercise and faster recovery after exercise in subjects receiving DAT. This
suggests that combining aerobic exercise with vitD repletion may help improve muscle
metabolic function. The hybrid NIRS/DCS instrument effectively measures muscle
hemodynamic and metabolic changes during and after exercise, and has potential for
continued high impact in translational studies combining techniques to comprehensively
understand skeletal muscle function.

2.5
2.5.1

APPENDIX: Other engineering work
Torque and position data acquisition
As mentioned in Chapter 2.2.6, torque and foot pedal position were recorded

during exercise. Torque and position were provided by the dynamometer as analog
outputs (voltage, 0 to 3.3 V). An Arduino based data acquisition system was built to
monitor and save the data.
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Figure 2.12 Torque and position data acquisition system.
The system is composed of Arduino Uno board, micro secure digital (SD) card module,
LCD module and a mode selection switch. Cable connections with dynamometer are
marked: Uno analog input channel 1 (A1) and channel 2 (A2) are connected to
dynamometer analog output channels of position signal (P) and torque signal (T). The
ground (GND) of dynamometer and Uno are also connected.

The system composition and cable connection are shown in figure 2.12. Arduino
Uno was selected for this project to cover all the needs. Analog input channel 1 and 2 of
Uno were employed to record position and torque signal respectively. A liquid crystal
display (LCD) screen was connected with Uno for data monitoring in real time. A mode
selection design was realized by a switch to select “monitor only” or “monitor and save”
mode. A micro secure digital (SD) card module was integrated into the system to save
the data.
Uno was programmed to realize the following function. When the system was
powered, Uno first checked the status of the micro SD card, an error message would pop
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out on LCD if the micro SD card was not in place. After initialization, the LCD
displayed the real time torque and position data in number, refreshed at 20 Hz. Data
saving started when the switch was pushed to “monitor and save” mode; A new txt file
was created at the same time in the micro SD card and Uno wrote torque and position
data in 2 separated columns into the file at 20 Hz until the switch was pushed back to
“monitor only”.

2.5.2

Automatic recognition of torque peak
Torque peak of each plantar flexion cycle during the exercise were calculated as a

secondary outcome of the measurement. An automatic torque peak recognition algorithm
with a graphical user interface (GUI) was developed using MATLAB to improve the
accuracy and free the labor form manual recognition and data logging.
The algorithm first converted the raw voltage signal of position and torque
collected with the above-mentioned system into meaningful values with correct units
after importing the raw data file. Then the 75 cycles were segmented using position
signal because position had more regular periodic pattern comparing with torque signal.
The torque peak value within each cycle was then calculated. The GUI displayed time
sequence of torque signal during exercise with torque peaks marked (Figure 2.13) and
allowed minor manual corrections (optional) by adding or removing torque peak points.
A cursor was provided to select the point to add/remove. The selection did not need to be
exact: the algorithm would allocate the nearest cycle/target to process. After finalizing all
torque peaks, results were saved to a txt file with assigned file name through the GUI.
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Figure 2.13 Graphical user interface (GUI) for automatic recognition of torque peak.
The GUI for automatic torque peak recognition is shown with workflow marked above.
The figure gives an example of manual removal of selected data point.
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CHAPTER 3. NONCONTACT DIFFUSE CORRELATION SPECTROSCOPY/TOMOGRAPHY
(NCDCS/NCDCT) FOR IMAGING OF MASTECTOMY SKIN FLAPS AND CHRONIC
WOUNDS

3.1

Introduction
Skin flap necrosis is the most common complication after mastectomy and

expander-implant based breast reconstruction, with an incident rate of up to 20% [6, 7,
42]. Occurrence of flap necrosis is associated with insufficient blood supply in flap to
meet the metabolic needs. Quantification of blood flow (BF) in mastectomy skin flaps is
important for the prediction and early salvation of the flap necrosis. Fluorescence
angiography has been used to measure tissue surface perfusion in the flap which may not
reflect BF in deep tissue of the skin flap. Also, measurements with fluorescence
angiography require invasive intravenous injection of dye. Furthermore, fluorescence
signal is transient and thus not suitable for continuous monitoring [13-15]. Fluorescence
imaging has been reported to over- or under-predict skin flap necrosis [15]. Therefore, a
technique for noninvasive and continuous quantification of flap BF is desired.
Chronic wounds affect more than 5 millions of Americans each year, among
which the prevalence of limb chronic ulceration approaches 15 percent and this number
keeps increasing [95]. The majority of chronic wounds can be classified into the
following three categories accordingly: diabetic foot ulcer, pressure ulcer, and venous
and arterial ulcers [3, 96]. Diabetic foot ulcers occur in 12 to 25 percent of patients with
diabetes [97]. Shunts in the microcirculation, together with the presence of neuropathy,
may lead to abnormal distribution of BF, which contributes to the wound development
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and disturbs the healing of the wound site [98]. Pressure ulcer occurs after tissue is
compressed over time. It originates from bone and develops upward to skin. Prolonged
pressure applied to the wound site reduces blood perfusion, which is a key factor to
prevent pressure ulcer from healing [4]. Peripheral arterial disease (PAD) is another
major cause of chronic wounds because of ischemia due to micro circulation
impairments. About 10 percent patients with PAD undergo vascular surgery to improve
perfusion in their limbs [99]. Adequate perfusion and hemodynamic success are not only
important judgment for revascularization surgery success, but also mandatory for healing
of chronic wound [100]. Again, a noninvasive portable device for reliable measurements
of BF distributions in wounds is needed for the diagnosis and treatment monitoring.
For vulnerable tissues like skin flaps and wound tissues, contact measurements
are not appropriate due to the risk of contact infections. On the basis of diffuse
correlation spectroscopy (DCS) technique, we developed an innovative noncontact
diffuse correlation spectroscopy and tomography (ncDCS/ncDCT) system for noncontact
spectroscopic and tomographic measurements of blood flow distributions in relatively
deep tissues [39, 41-43, 101]. The ncDCS/ncDCT system employs optical lens to project
DCS sources and detectors on the tissue surface. A noncontact probe is mounted on a
motorized-drive linear stage for mechanical scanning over a selected region of interest
(ROI) for tomographic measurements. A finite element method (FEM) based diffuse
correlation tomography (DCT) image reconstruction algorithm has been developed based
on a modified open-source software package NIRFAST, which was originally designed
for diffuse optical tomography (DOT) reconstruction [39, 41]. The ncDCS/ncDCT
system has been validated in tissue-like phantoms and in in vivo tests. It has also been
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applied for imaging of breast tumors and head/neck free tissue transfer flaps [39, 41, 82,
101].
In this project, I optimized and applied ncDCS for spectroscopic measurements of
BF in mastectomy skin flaps intraoperatively with the hypothesis that ncDCS
measurement could provide intraoperative BF data to enable the prediction of
mastectomy skin flap necrosis [43]. I also applied ncDCT for tomographic imaging of
BF distributions in chronic wounds to measure the BF contrast between wound tissue
and normal tissue.

3.2
3.2.1

Methods
ncDCS/ncDCT instrumentation
The ncDCS/ncDCT probe for noncontact blood flow measurement is shown in

Figure 3.1. The noncontact probe has two identical laser source paths and one shared
detector path in the center arranged in a linear array (Figure 3.1) [39, 41-43]. In each
source path, laser light delivered through a multimode source fiber is projected onto the
tissue surface through lens system (Figure 3.1). Fifteen single-mode detector fibers are
evenly distributed in 7 mm to cover a 20 mm range on the focus plane (measurement
surface) through the lens magnification (Figure 3.1). With this setup, the source-detector
(S-D) separations range from 10 to 30 mm, which enables maximum penetration depth
of ~15 mm (half of the S-D separation) [78, 81].
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Figure 3.1 ncDCS/ncDCT probe and experimental setup for wound imaging.
There are two separated source paths and one shared detector path integrated in the
probe. Sources and detectors are projected/focused to tissue surface through lens
apparatus. The noncontact probe is fixed to a motorized linear stage at ~10 cm above
tissue surface. S-D: source-detector.

This noncontact probe is connected to a DCS flowmetry device through optical
fibers. Photons emitted from lasers are injected through the source path into the tissue
sample. Photons travel through the tissue and reflect back to detectors (avalanche
photodetector (APD)) through detection path. The correlator takes the APD outputs and
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calculates the light intensity autocorrelation functions, which are used to extract tissue
blood flow information.
The noncontact optical probe is mounted on a linear motorized stage which is
fixed to a multiple axis stand holder for flexible adjustment of probe position. The
motorized stage can be fixed at one location for spectroscopic measurements or driven
linearly using computer program for linear scanning over the ROI for tomographic
measurements.

3.2.2

DCT reconstruction
Surface geometry acquisition and mesh generation. FEM-based DCT

reconstruction requires incorporating a finite element mesh to represent the imaged tissue
volume and to denote locations of the sources and detectors along the surface [39-41].
For some simple cases, we may use a mesh with simple geometry, such as sphere or slab
shape, to approximate the tissue geometry. While for many cases, the tissue surface
geometry is complicated and requires more accurate geometry characterization for better
reconstruction.
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Figure 3.2 Mesh generation.
The surface geometry (a) captured by the 3D camera is used to generate a surface shell
(b). A solid body (c) representing the measured tissue volume is generated from the
surface shell. Source and detector locations are calculated on the surface of the solid
model based on the marks. Finally, the solid model is divided into a solid mesh (d).

In this study, a commercial 3D scanner (NextEngine, CA) was used to scan target
sample geometry. The working distance of the 3D scanner was about 17 inches from the
sample surface. Prior to geometry acquisition, reference marks were made manually
using marker pen on the measurement surface at the projected source locations of the
beginning and ending step of the ncDCT scanning (Figure 3.2 (a)). These markers were
used for assignment of sources and detectors on the mesh surface. During the 3D
geometry scanning, a reference plane parallel to the focus plane of ncDCT was included
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in the field of view (FOV) of 3D scanner for easy alignment of the geometric
information and boundary ncDCT data. The output of the 3D scanner was the tissue
surface geometry (Figure 3.2 (b)).
A solid model was then created to extend the surface shell into a solid body
(SolidWorks, Dassault Systemes, MA) (Figure 3.2 (c)). The projected sources and
detectors were calculated based on this 3D model and the reference marks made on the
tissue surface using a program implemented in SolidWorks interface (Figure 3.2 (c))
[40]. Finally, a 3D tetrahedron mesh was generated using ANSYS® (ANSYS, PA) from
the solid model created in SolidWorks with an appropriate node distance (typically 2 mm
in this study) (Figure 3.2 (d)).
Modified NIRFAST for DCT reconstruction. Many DOT methods have been
developed for reconstructing 3D tissue heterogeneity from NIRS measurements at
multiple S-D pairs [21-23]. For example, NIRFAST is a FEM-based open source
software package for DOT image reconstruction [102]. Similar to DOT, DCT
reconstructs blood flow image using DCS measurements from multiple S-D pairs.
Because of mathematical similarity of the correlation diffusion equation (Equation 2.7)
and the photon diffusion equation (Equation 2.2), the NIRFAST algorithm for DOT was
1

modified and adapted by our group for DCT reconstruction [39, 102]: the term 3𝜇𝑠′ 𝑘02
𝛼〈∆𝑟 2 (𝜏)〉 in Equation 2.7 was written as 𝜇𝑎𝑑 (𝒓, 𝜏) = 2𝜇𝑠′ 𝑘02𝛼𝐷b(𝒓)𝜏, and defined as
“dynamic absorption” at correlation delay time 𝜏.

DCT was conceptualized as a

formulation of continuous-wave (CW) DOT (ω = 0) which computed 𝐺1 (𝒓, 𝜏) instead of
photon fluence rate Φ(𝒓, ω), by updating “static absorption” 𝜇𝑎(𝒓) to 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏) = 𝜇𝑎(𝒓)
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+ 𝜇𝑎𝑑 (𝒓, 𝜏) at a selected 𝜏, and reconstructing 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏) instead of 𝜇𝑎(𝒓) only. The
reconstructed 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 was used to extract 𝛼𝐷b (blood flow index (BFI)).
Chart 3.1 shows the execution of DCT reconstruction using our modified
NIRFAST. First, a mesh representing the imaged tissue volume is loaded. All the sources
and detectors according to the actual ncDCT scanning are assigned onto the surface of
the mesh. S-D pairs corresponding to the actual tissue boundary are linked to match with
the boundary data. Initial guess of BFI and optical properties ((𝒓) and 𝜇𝑠′ (𝒓)) of each
mesh voxel, along with the selected 𝜏 = 𝜏0 are assigned to the mesh. An initial guess of
𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏0) is then calculated. Boundary BFI data from ncDCT scanning are converted
to 𝑔1(𝒓, 𝜏0) using Equation 2.9 and further converted to 𝐺1(𝒓, 𝜏0) by multiplying with
𝐺1(𝒓, 0) [39].
We then ran the inverse model with an iterative approach for the reconstruction of
spatial distribution of 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏0) and BFI [39]. A forward model was first run to
calculate the boundary 𝐺1(𝒓, 𝜏0) based on the initial guess of the mesh in the first
iteration or based on the updated mesh in the following iterations. The discrepancy
between the boundary 𝐺1(𝒓, 𝜏0) from our measurements and those from the
initial/updated data was then calculated and minimized. If the reminding error was larger
than the tolerance, an update for 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏0) is calculated accordingly. These iterations
ran continuously until the remaining error was under the tolerance. Finally, BFI
distributions were extracted through the definition of 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏).
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Chart 3.1 Flowchart of the modified NIRFSAT for DCT reconstruction.

3.2.3

ncDCS for measurements of blood flow in mastectomy skin flaps
Patient recruitment. The experimental protocol was approved by University of

Kentucky (UK) Institutional Review Board (IRB) (#15-0511-F2L). Female patients over
18 years old undergoing mastectomy and immediate breast reconstruction were recruited
from the UK hospital with signed consent form.
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Data collection & analysis. For each patient, blood flow was measured at three
time points using ncDCS before and immediately after mastectomy, and immediately
after breast reconstruction (Figure 3.3). For this study, one source path (laser at 785 nm)
and 4 detector paths located at 10.0, 14.2, 18.6, and 22.8 mm distances from the source
location were used to cover tissue flaps with penetration depths of 5 to 11.4 mm. At each
time point, blood flow was measured from two to three equidistant locations along both
sides of the edge of the mastectomy incision. Thirty frames of data were taken at each
location. Total measurement time at each time point was less than 5 minutes.

Figure 3.3 Mastectomy skin flap measurement setup.
Measurement set up at before (a), immediately after mastectomy (b), and after breast
reconstruction (c).

BFIs were averaged over all locations and all S-D separations for each time point,
and then normalized to the baseline level before mastectomy (assigning “1”) to get rBF.
All subjects were followed for at least 5 months for the development of mastectomy skin
flap necrosis defined as any area of skin necrosis on the skin flap. Statistical tests for
averaged rBF differences at different time points were performed using Welch two
sample t-test. The receiver operating characteristic (ROC) curve was constructed and the
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area under the ROC curve (AUC) was calculated to evaluate the ability of rBF
measurements to discriminate necrosis and non-necrosis groups. All analysis was
performed using MATLAB.

3.2.4

ncDCT for 3D imaging of chronic wounds
Patient recruitment. The experimental protocol was approved by UK IRB (#14-

0571-F1V). We planned to recruit 20 patients with deep tissue wound (e.g., pressure
ulcer, diabetic foot ulcer, arterial ulcer) in total from UK hospital Wound Care Clinic
(WCC). Among the 20 subjects, we expected to recruit 10 PAD patients who will
undergo revascularization and measure them twice at before and after the surgical
intervention to evaluate hemodynamic improvements. The following populations were
excluded during subject screening: 1) pregnant females; 2) patients under 18 years old;
3) patients with very limited mobility. Because of the instrumentation limitation (i.e.
limited coverage of the ncDCT probe), only patients with wound size under 100 × 20
mm2 were considered for this study. Patients who passed our screening and agreed to
participant in the study were measured at the UK Center for Clinical and Translational
Science (CCTS).
Data collection & analysis. For each measurement, tissue blood flow in the
selected wound and the surrounding normal tissue (total coverage of ncDCT scanning on
tissue surface: ~ 40 × 100 mm2, centered at the wound) were imaged using the ncDCT
system (Figure 3.1). For this protocol, both source and detector paths on the ncDCT
probe were used for noncontact scanning. Step separation (typically 6 mm) and total
number of linear scan steps were determined based on the size of the wound (typically ~
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16 steps in total). Each scanning covered the wound and some surrounding normal tissue
(total coverage: ~ 40 × 100 mm2, centered at the wound). At each step, 20 frames of data
were obtained.
During the measurement, the patient was asked to lie in the supine position (or
bend over if the wound is on the back) to expose the wound site. Subsequently, ncDCT
scanning was obtained using the noncontact probe. The scanning time ranged from 4 to 6
minutes depending on the wound size and sampling density. A 3D photo was taken
targeting the same location using the commercial 3D scanner to get tissue surface
geometry. The actual source positions at the first and last steps were marked during the
ncDCT scanning and included in the 3D photo for S-D coordinate. Each measurement
took less than 30 minutes, including preparation, ncDCT scanning, 3D photo acquisition
and wound bandaging after the optical measurements.
For each measurement, 3D blood flow distribution in the wound and the
surrounding normal tissue was reconstructed. The scanning data was processed using
Equation 2.5 and 2.9 to get a complete set of boundary 𝛼𝐷b. A mesh with real tissue
geometry was generated using the method described in Chapter 3.2.2. The DCT
reconstruction was done using our modified NIRFAST (Chapter 3.3.2). A single delay
time 𝜏 = 3.2 × 10−6 𝑠, and optical properties of 𝜇𝑎 = 0.025 cm-1, 𝜇𝑠′ = 7.0 cm-1 were used
in flow image reconstruction.
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3.3

Results

3.3.1

Prediction of mastectomy skin flap necrosis
Nineteen patients were enrolled in the study. Four patients (21%) developed skin

necrosis, one of which underwent additional surgery (patient #4). The rBF values
immediately after mastectomy and after reconstruction of each patient are shown in
Table 3.1. The difference in rBF immediately after mastectomy in patients with or
without necrosis was statistically significant (Fig. 3.4 (a)), with values of 0.27 ±0.11 and
0.66 ± 0.22, respectively (p < 0.001). rBF values immediately after mastectomy showed
a significant high accuracy in prediction of skin flap necrosis, with an AUC of 0.95 (95%
confidence interval = 0.81, 1) (Fig. 3.4(b)).

Table 3.1 rBF values in mastectomy skin flaps of 19 patients
Patient

Necrosis?

Before
mastectomy

After
mastectomy

After
reconstruction

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

N
N
N
Y
N
N
Y
N
N
N
N
Y
N
N
N
N
N
N
Y

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

0.51
0.51
0.81
0.12
0.8
1.05
0.37
0.81
0.52
0.24
0.53
0.29
1.07
0.76
0.72
0.66
0.52
0.46
0.31

1.07
1.39
1.36
0.35
0.45
0.39
0.6
0.58
0.97
0.5
0.72
1.16
0.91
0.85
1.04
1.26
0.52
0.29
0.27
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rBF after reconstruction showed the same trend with 0.58 ± 0.40 in patients who
developed necrosis and 0.82 ± 0.36 in patients who did not develop necrosis ((Fig.
3.4(c)(d)), while no statistical significance (p = 0.35) was observed. rBF values after
reconstruction showed poor ability in prediction of skin flap necrosis, with an AUC of
0.68 (95% confidence interval = 0.17, 1) (Fig. 3.4(d)).

Figure 3.4 Prediction of mastectomy skin flap necrosis.
(a) Relative blood flow changes (rBF) immediately after mastectomy from 19 patients
including 4 with mastectomy skin flaps necrosis (patient 4, 7, 12, and 19, marked with
black bars). Error bars represent rBF variations (standard deviations) at different depths
of the mastectomy skin flap. (b) AUC data immediately after mastectomy for
discriminating mastectomy skin flaps with necrosis (n = 4) and without necrosis (n = 15).
(c) rBF after reconstruction from 19 patients. (d) AUC data after reconstruction for
discriminating mastectomy skin flaps with necrosis (n = 4) and without necrosis (n = 15).
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3.3.2

3D imaging of chronic wounds
Five subjects with chronic wounds were recruited and measured. There was no

PAD patient undergoing revascularization recruited in this study. Two of the five
scanning were contaminated with significant motion artifacts since the patients moved
significantly during noncontact scanning creating big difficulty for measurement
alignment and were not processed for DCT reconstruction. The three successful cases
included one with pressure ulcer, one with diabetic ulcer, and one with a non-healing
traumatic injury.
The pressure ulcer (Figure 3.5) and diabetic ulcer (Figure 3.6) had a circular
wound with similar size (~1 cm in diameter). The non-healing traumatic injury case
(Figure 3.7) had a long and narrow wound (~8 cm long and ~1 cm width). The
reconstructed BF distributions showed similar pattern in the three cases: higher BF
contrast (higher and lower rBF levels comparing to background) was found close to the
wound. BF variations are seen both on the surface and in deep tissue while larger BF
contrasts mainly appeared on the tissue surface close to the wound margin. In addition,
blood flow variations were relatively smaller in the surrounding tissues away from the
wound.

rBF contrasts (rBF relative to the normal surrounding tissues) over the

reconstructed tissue volume were ranging from 0 to 4.0 in the pressure ulcer, from -0.2 to
3.0 in the diabetic ulcer, and from 0.0 to 3.8 in the non-healing traumatic injury,
respectively.
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Figure 3.5 DCT results from the pressure ulcer case.
(a) Surface color image overlays with the surface BF distributions. (b) Surface and cross
section views of relative blood flow changes (rBF) distributions.

Figure 3.6 DCT results from the diabetic ulcer case.
(a) Surface color image overlays with the surface BF distributions. (b) Surface and cross
section views of relative blood flow changes (rBF) distributions.
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Figure 3.7 DCT measurement results from the non-healing traumatic injury case.
(a) Surface color image overlays with the surface BF distributions. (b) Surface and cross
section views of relative blood flow changes (rBF) distributions.

3.4

Discussion and conclusions
Prediction of mastectomy skin flap necrosis. We have demonstrated the

feasibility of ncDCS for intraoperative measurements of tissue blood flow in the
operating room without interfering with the sterility of surgical setup. The ncDCS has
negligible risk comparing to other imaging modalities for intraoperative measurement
because of the lack of dye injection or direct contact with patient.
Patients who developed mastectomy skin flap necrosis had significantly lower
rBF values at immediately after mastectomy (Figure 3.4(a)) comparing with patients
who did not develop mastectomy skin flap necrosis, demonstrating the potential of
ncDCS for the intraoperative prediction of necrosis risk [43]. Interestingly, the only
patient (patient # 4) who required additional surgery had the lowest rBF immediately
after mastectomy (Figure 3.4(a)), indicating a possible correlation between the
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severity/extent of the mastectomy skin flap necrosis and the rBF value immediately after
mastectomy. More subjects are needed to establish a model between risk level of
necrosis and rBF values.
rBF values after reconstruction showed the same trend that lower values were
obtained from patients who developed mastectomy skin flap necrosis (Figure 3.4(c))
without reaching statistical significance. Furthermore, rBF after reconstruction
demonstrated poor discriminating ability of mastectomy skin flap necrosis (Figure
3.4(d)). rBF after reconstruction also showed larger variations comparing with those
immediately after mastectomy (Figure 3.4), which may be partly attributed to the
presence of the tissue expander or implant after reconstruction.
3D imaging of BF distributions in skin flaps can significantly increase spatial
resolution and enable precise prediction of necrosis volume and location for excision.
However, limited by the long mechanical scanning time and poor spatial resolution,
ncDCT imaging could affect surgical workflow in the operating room.
Imaging of chronic wounds. We have successfully applied ncDCT technique for
3D imaging of chronic wounds. Our preliminary results showed that tissue heterogeneity
can be captured by the 3D imaging in relatively deep tissues. Given the burden of longterm care for chronic wounds, this translational technology has the potential to facilitate
better understanding of deep tissue wound development and healing process, and may
lead to improvements in wound management and substantial cost savings in the future.
For example, pressure ulcer originates from bone and develops upward to tissue surface.
Hemodynamic changes in deep tissue occur before the ulcer is evident on tissue surface
[4, 103]. Therefore, imaging of deep tissue hemodynamics in population with risk of
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pressure ulcer may help on the prevention and early diagnosis of pressure ulcer. Previous
study in PAD patients undergoing revascularization surgery showed that oxygenation
level in the treated foot has significant increase after the surgery, indicating that
hemodynamic measurement could be used to validate the success of the treatment [104].
Adequate perfusion and hemodynamic success are not only important judgment for the
success of revascularization surgery, but are also mandatory for healing of chronic
wound [100]. Thus, imaging of deep tissue hemodynamics should provide important
information on the prediction of wound healing and on the validation of treatment
outcome of various types of chronic wound.
For the chronic wound study, we experienced difficulty in subject recruitment. In
order to participant in this study, subjects were asked to travel from WCC after their
clinic visit to CCTS. Although free public transportation and free parking were available,
it was still hard and inconvenient for the potential subjects since most of them had other
chronic diseases or health issues besides the wound, which all together limited their
mobility significantly. In addition, because of the limited coverage of the ncDCT system,
only small wounds were imaged.
Limitations of ncDCS/ncDCT system. The ncDCS/ncDCT system has some
limitations when applying in clinical settings. The motorized linear stage enables lateral
scanning along the surface of ROI and allows relatively dense sampling by assigning
relative short step separation. However, the fixed linear S-D array limits longitudinal
coverage of scanning and leads to poor spatial resolution. Motion artifacts may
contaminate boundary data and result in difficulty for S-D alignment. The step-by-step
scanning in relatively low speed also makes ncDCT system impractical for catching fast
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transient changes in tissue hemodynamics. Since ncDCS/ncDCT system uses optical
fibers and expensive APDs, it is difficult to improve temporal and spatial resolution.

59

CHAPTER 4. SPECKLE CONTRAST DCT (SCDCT) FOR IMAGING OF WOUNDS

4.1

Introduction
Imaging of blood flow (BF) distributions in burn wounds can provide essential

information for determining the ischemic area that requires wound excision or skin
grafting to ensure successful surgical outcomes [1]. As reviewed early in Chapter 3,
although noncontact diffuse correlation spectroscopy and tomography (ncDCS/ncDCT)
can measure BF distributions in vulnerable tissues including wounds, they have limited
temporal and spatial resolution and limited size of region of interests (ROI) for BF
imaging because of limited sources/detectors and long mechanical scanning. Very
recently, our lab proceeded from avalanche photodetector (APD) to camera detection for
blood flow imaging, which significantly increases temporal/spatial resolution and
eliminates the needs of mechanical scanning. This novel optical imaging technique is
termed speckle contrast DCT (scDCT) [44-46]. The scDCT employs a focused point
source and a galvo mirror to remotely project point light onto source locations over a
selected ROI. The optical zoom lens in front of the camera enables fully noncontact
detection of BF and flexible adjustment of ROI. As mechanical scanning is no longer
needed, scDCT enables fast data acquisition, which is desirable for use in the operating
room. Thousands of pixels provided by the camera significantly improve spatial
resolution of imaging. The scDCT system has been tested for BF imaging using tissuesimulating phantoms and in vivo tissues.
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The scDCT technique extracts boundary BF information from the spatial
distribution of diffuse laser speckles detected by the camera. Boundary BF data is input
to the modified NIRFAST program (see Chapter 3.2.2) for three dimensional (3D)
tomographic reconstruction of BF distributions. In addition, we have developed two
dimensional (2D) mapping method, which requires less computation time (several
minutes) compared to 3D reconstruction (several hours) [105], although it sacrifices the
depth information.
One limitation with the current scDCT technique is the potential influence of
unknown tissue optical properties such as µa on BF measurements [25, 47, 106]. For the
current approach of blood flow index (BFI, i.e. αDB) quantification from diffuse speckle
contrasts, we assume constant optical properties (absorption coefficient: 𝜇𝑎 , reduced
scattering coefficient: 𝜇𝑠′ ) for the entire tissue volume. However, it has been reported that
different types of tissues or tissues with different diseases have varied optical properties
[85, 107]. Assuming inaccurate optical properties may lead to error in αDB calculations
[108-110]. Therefore, new algorithms to overcome this limitation are desired [106, 109,
111].
In this study, I optimized and tested the scDCT system using tissue-simulating
phantoms and in human forearms with arterial occlusions to validate the capability of the
scDCT system on imaging spatial and temporal flow changes. I applied the scDCT
system for the first time to image burned wounds [47]. Lower BF was expected in burnt
tissue comparing with surrounding normal tissue. I also developed and validated a new
algorithm for extracting both αDB and 𝜇𝑎 from the measured light intensities and speckle
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contrasts at multiple S-D distances collected by scDCT system in order to get rid of the
influence of 𝜇𝑎 on αDB calculation.

4.2

Methods

4.2.1

scDCT instrumentation
Figure 4.1 shows the scDCT system configuration [45]. Two cameras were tested

including an electron-multiplying charge coupled device (EMCCD; Cascade 1K,
Photometrics, AZ) and scientific complementary metal–oxide–semiconductor (sCMOS;
Hamamatsu Orca Flash 4.0LT) in the scDCT system. Camera specifications are listed in
Table 4.1. The sCMOS camera has higher frame rate (30 frame per second (fps))
comparing with the EMCCD (~10 fps), which benefits a faster sampling.

Table 4.1 Specifications of Cascade 1K and Orca Flash 4.0LT
Cascade 1K

Orca Flash 4.0LT

Sensor type

EMCCD

sCMOS

Pixel number

1004 × 1002

2048 × 2048

Pixel size

8 µm × 8 µm

6.5 µm × 6.5 µm

Sensor size

8.032 mm × 8.016 mm

13.312 mm × 13.312 mm

Well capacity

30,000

30,000

Frame rate

10Hz

30Hz

AD conversion

16 bits

16 bits

The camera with a large number of pixels increases significantly sampling density
and spatial resolution. It also eliminates the need of mechanical scanning in ncDCT, and
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thus shortens the measurement time and avoids motion artifacts. NIR point-source light
at 830 nm from a long-coherence laser (Crystalaser) is delivered through a multimode
fiber (core size: 200 microns) to an achromatic lens (AC127-019-B, Thorlabs), and then
to a galvo mirror (GVS002, Thorlabs). The galvo mirror projects NIR light to different
source positions in ROI. Very recently, a pinhole was added into the source light path
between the achromatic lens and the galvo mirror to sharpen the projected laser spot on
the measured tissue/phantom.

Figure 4.1 scDCT system configuration.
The EMCCD/sCOMS camera is focused by a zoom lens onto the tissue surface. A long
coherence laser is connected through an optical fiber to lens and polarizer. The focused
source light spot is projected by the galvo mirror onto the measured tissue surface. S1:
source 1, D1/D2: detector 1/2.
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A zoom lens (Zoom 7000, Navitar) is mounted to the camera enabling easy
adjustment of ROI. The camera detects diffuse light from tissue surface in a reflectance
mode, which is more practical and flexible for applications in large volume tissues,
where transmission mode is impractical due to limited penetration depths of light. In
order to reduce the direct reflection of the source light from the tissue surface, a pair of
polarizers (LPNIRE050-B and LPNIRE200-B, Thorlabs) is added in source light path
and in camera detection path. A long-pass filter (84-762, Edmund Optics, NJ) is added in
front of the zoom lens to minimize the influence of room light. The noncontact scDCT
probe is fixed on an articulated arm for flexible positioning and accurate focusing on the
ROI. The scDCT system is controlled by a LabView program for accurate projection of
source light to desired locations and the sequential collection of images.

4.2.2

3D reconstruction of blood flow distributions
The concept of speckle contrast comes from laser speckle contrast imaging, where

typically a wide-field illumination is applied over a ROI and a camera is used for
detecting laser speckle fluctuation on superficial tissue surface [112, 113]. By contrast in
scDCT technique, a focused point laser source is used to deliver NIR light into the deep
tissue. An EMCCD/sCOMS camera is used to detect diffused laser speckle fluctuation,
resulting from motion of red blood cells. The diffuse speckle contrast is defined as:
σ

Ks(r) = 〈I〉𝑠 ,

(4.1)

Here, σs is the spatial or temporal standard deviation of light intensity and 〈I〉 is
the mean intensity of a set of pixels, r is the distance of the pixels from the source
location.
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From the Siegert relationship (Equation 2.5), the speckle contrast Ks(r) can be
related to the temporal correlation function g1 as the following [44]:
Ks(r)2 =

2β
𝑇

𝑇

𝜏

2
∫0 (1− 𝑇) [g1(r, τ)] dτ;

(4.2)

Where T is the exposure time.
By substituting g1 with its analytical solution (Equation 2.9) to Equation 2.7 in
semi-infinite geometry, a nonlinear relationship between Ks(r) and αDB can be
established, where Ks(r) can be written as a function of αDB, together with other
parameters [44]:
Ks(r)2 = 𝑓(αDB, 𝑇, 𝜇𝑎, 𝜇𝑠′, 𝜆, 𝛽, 𝑘0, 𝒓)

(4.3)

Where 𝜆 is the wavelength of the source light and 𝑘0 is the wavenumber. For each
fixed set of αDB, 𝜇𝑎, 𝜇𝑠′, 𝜆, 𝛽 and 𝑘0, the nonlinear relationship between the diffuse
speckle contrast (K), S-D separation (𝒓) and exposure times (T) is shown in Figure 4.2.

Figure 4.2 Variations in speckle contrasts over a range of S-D separations and
exposure times.
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We extract αDB from the speckle contrast at a single S-D separation and a single
exposure time (i.e., a single data point on the surface shown in Figure 4.2) [44, 45]. The
speckle contrast can be experimentally measured and calculated (Equation 4.1) from
images taken by the camera. In the right-hand side of Equation 4.3, 𝑇, 𝜆, 𝑘0 and 𝒓 are
known or measurable, 𝜇𝑎, 𝜇𝑠′ and 𝛽 can be estimated from literatures. Therefore, αDB is
the only unknown variable. By assigning a value for αDB, a theoretical diffuse speckle
contrast can be calculated using Equation 4.3. Finally, αDB is determined by searching
for the value of αDB that minimizes the square difference between the measured speckle
contrast and the theoretical speckle contrast.
The αDB extracted from scDCT is equivalent to that obtained from APDs
measurement in ncDCT as introduced in Chapter 3. Therefore, scDCT reconstruction of
3D blood flow distributions can be performed in the same manner as ncDCT [44, 45].

4.2.3

2D mapping of blood flow distributions
2D mapping of BF distributions projects boundary BF measurements onto a 2D

mesh of FOV, which saves computation time comparing with DCT reconstruction. The
procedures of 2D mapping are introduced below [105]. For each linked S-D pair, BFI is
first calculated using the method introduced in Chapter 4.2.2. The midpoint was then
calculated for the S-D pair as the center location between the source and the detector
(Figure 4.3). The boundary BFI is then projected to the midpoint location to represent
the S-D pair. This is because the midpoint matches better to the realistic sensitive region
of the diffuse light with a banana photon pathway for the manipulated S-D pair.
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Figure 4.3 Flowchart of 2D mapping algorithm.
S-D: source-detector.

After BFI and midpoints over all linked S-D pairs are calculated, spatial merging
and smoothing are done. For each midpoint, a subset of S-D pairs within a neighborhood
radius based on midpoint location is identified. The average or weighted average of the
BF measurements corresponding to this subset are calculated and projected to the
manipulated midpoint location as the final BF value for this location.
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4.2.4

Phantom tests
Tissue-like phantoms with known optical properties are commonly used in optical

instrument calibration and validation. The liquid phantom consists of distilled water,
India ink (Black India, MA) and intralipid (Fresenius Kabi, Sweden). The intralipid
particles in the liquid phantom provide control of μ′𝑠 and Brownian motion (particle
flow) while India ink provides control of µa.
In this study, the optical properties of the homogeneous phantom were set as µa =
0.05 cm−1 and μ′𝑠 = 8 cm−1 to match the realistic biological tissues. The homogeneous
liquid phantom was filled into a water tank as the background. Two heterogeneous
phantoms were created to validate the scDCT system by embedding two different
anomalies with increased or decreased flow contrast respectively into the homogeneous
phantom.
In the first heterogeneous phantom, a transparent plastic cylindrical tube
(diameter = 6 mm, length = 80 mm) connected with a peristaltic pump (HV-77201-60,
Cole Parmer, IL) through soft rubber tube was placed 5 mm (tube center to liquid
phantom surface) beneath the surface of the background liquid phantom to create high
flow contrasts at different levels against the background liquid phantom. The tube lay
across the center of ROI along x direction (Figure 4.4 (a)). The tube was mostly stuffed
with small pieces of solid phantom (composition: titanium dioxide, silicon and carbon
black) with the same optical properties as the background liquid phantom to randomize
the particle motion as random flow inside the tube. The tube was then filled with the
same liquid phantom and the liquid was pumped by the pump to create step increases in
steady flow from 0 to 20 ml/min at 5 ml/min increment in the tube.
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In the second heterogeneous phantom, two sphere shape solid phantoms (μa =
0.05 cm−1, μ′𝑠 = 8 cm−1, flow = 0) at diameter of ∼7 mm were placed at 5 mm (sphere
center to background phantom surface) beneath the surface of background liquid
phantom at the locations of X-Y planes (15, 15 mm) and (−15, −15 mm) respectively to
create low flow contrasts against the background liquid phantom (Figure 4.4 (a)). A thin
iron wire penetrating through the centers of the two sphere solid phantoms was used to
hold the two anomalies in place.

Figure 4.4 Phantom tests with scDCT.
(a) Source-detector (S-D) configuration for phantom tests: region of interests (ROI) = 80
× 80 mm2; dimension and locations of anomalies. (b) S-D configuration for forearm
occlusion test: ROI = 40 × 40 mm2

For scDCT data collection, the EMCCD (i.e., Cascade 1K in Table 4.1) was used.
An ROI of size 80 × 80 mm2 was selected to cover the anomalies region (Figure 4.4 (a)).
The galvo mirror projected 830 nm source light to 9 × 9 source locations (1 cm
separation from each) in the ROI. For each scanning, 4 frames of EMCCD images were
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taken at each source location. 41 × 41 detectors (2 mm separation from each) were
evenly defined in the ROI for image reconstruction. Sources and detectors within S-D
separation range of 7 to 19 mm werelinked for boundary data calculation and DCT
reconstruction. Image reconstructions were processed using a 100 × 100 × 30 mm3 slab
mesh centered at (0, 0, 15 mm) with 4 mm distance nodes and refined 1.3 mm distance
nodes in the center (∼60K nodes in total) to improve the reconstruction resolution in the
targeted area.

4.2.5

Imaging of forearm blood flow
The scDCT is tested for continuous imaging of BF changes in a healthy human

forearm. The BF change in forearm was induced by a 4-minute arterial occlusion at a
pressure of 230 mmHg applied on the upper arm. The EMCCD (i.e., Cascade 1K in
Table 4.1) was used in this test. An ROI of 40 × 40 mm2 was selected on the subject’s
forearm (Figure 4.4 (b)). 5 × 5 sources separated by 1cm of each were used for the data
collection. 21 × 21 detectors were evenly defined for boundary BF calculation. Image
reconstruction was processed on a 60 × 60 × 30 mm3 slab mesh centered at (0, 0, 15 mm)
with 2 mm distance nodes (∼20K nodes in total).

4.2.6

Imaging of wounds
The experimental protocol has been approved by University of Kentucky (UK)

Institutional Review Board (IRB) (#14-0571-F1V) [47]. Patients with burn wound were
recruited from UK hospital. scDCT imaging was done in the operating room prior to
wound excision and grafting (Figure 4.5 (a)). The EMCCD (i.e., Cascade 1K in Table
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4.1) was used in this study. A ROI of 80 × 80 mm2 was selected to cover an area with
burned tissue and adjacent unburnt tissues. 9 × 9 sources were evenly distributed over the
ROI with 1 cm separation between each for data acquisition (Figure 4.5 (b)). The
exposure time used in this study was 5 ms. Two frames of raw images were acquired and
averaged at each source location.

Figure 4.5 Imaging of BF distributions in burn wounds with scDCT system.
(a) Experimental set up in the operating room. scDCT imaging is focused onto the
selected area across the burned wound and surrounding normal tissue. (b) The sourcedetector arrangement over the region of interests.

41 × 41 detectors with 2 mm separation between each were evenly defined over
the ROI (Figure 4.5 (b)). Each detector region was defined as binding 3 × 3 adjacent
pixel windows while each pixel window consisted of 7 × 7 pixels. Spatial speckle
contrast was first calculated for each of the 9 pixel windows. Speckle contrast of the
detector was then calculated by averaging the speckle contrasts over the 9 pixel windows
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and over the two frames to enhance signal-to-noise ratio [44, 45]. S-D separation was
calculated as the distance from the center of the source light spot to the center of each
detector region. Pre-processing of raw data including shot noise removal, dark noise
removal and smear correction were performed prior to speckle contrast calculations.
Speckle contrasts at the S-D separations of 7 to 19 mm were then calculated as boundary
data [44, 45].
Boundary BFI data were normalized to their mean value (assigning “1”) to
calculate relative change of BF (rBF). The normalized boundary rBF were then used as
input for 3D tomographic reconstructions of BF distributions in the targeted tissue
volume using the modified NIRFAST and for 2D mapping of BF distributions. For the
3D reconstruction, a slab shape tetrahedral mesh with a volume of 100 × 100 × 30 mm3
and node distance of 2 mm was used for 3D image reconstruction. In this study, we only
recruited patients with burn on body part(s) with relatively flat surface. Thus, a slab
mesh was used to approximate tissue geometry without introducing much errors related
to irregular geometry. A neighborhood radius of 6 mm was used for 2D mapping.
Results from 3D reconstruction and 2D mapping were compared.

4.2.7

Simultaneous extraction of absorption coefficient (µa) and blood flow index
(αDB)

Recalling Equation 4.3, speckle contrast is a function of multiple parameters
including αDB and optical properties (µa and µs’). The assumption of optical properties
may lead to errors in αDB calculations. Therefore, developed a new algorithm that
enables extraction of both µa and αDB from the measured light intensities and speckle
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contrasts at multiple S-D distances. This algorithm employs a two-step approach: first, µa
is calculated from the measured light intensities at multiple S-D distances; second, αDB
is calculated from the speckle contrast at multiple S-D distances with the input of µa
obtained in the first step. Details of these steps are described below.
The simplified solution of photon diffusion equation is given as [23, 105, 111]:
ln[I(r) r2] = k – r 𝜇𝑒𝑓𝑓

(4.4)

Here I(r) is the light intensity I at S-D separation r, k is a constant, μ𝑒𝑓𝑓 is the
effective attenuation coefficient defined as:
𝜇𝑒𝑓𝑓 (λ) = √3 𝜇𝑎 (𝜆) ∙ 𝜇𝑠′ (𝜆)

(4.5)

Note that the premise of Equation 4.4 is r ≥ 1cm [23, 105]. ln[I(r) r2]
approximately has a linear relationship with r when this condition is met. μ𝑒𝑓𝑓 can be
fitted from light intensities at multiple S-D distances since μ𝑒𝑓𝑓 is the slope in this linear
model. By assuming 𝜇𝑠′ , 𝜇𝑎 can be calculated by fitting μ𝑒𝑓𝑓 (Figure 4.6 (a)).
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Figure 4.6 Two-step approach for extraction of µa and µs’.
(a) Fitting effective attenuation coefficient (µeff) from light intensities measured at
multiple source-detector (S-D) separations. (b) Fitting blood flow index (αDB) from
speckle contrasts measured at multiple S-D separations.

The second step of the algorithm is to fit αDB from the measured speckle contrasts
at multiple S-D distances by minimizing the penalty term defined as [106, 109, 110,
114]:
𝑁

𝑟
2
χ2 = ∑𝑖=1
[ 𝐾𝑚
(𝑟𝑖 , αDB) - 𝐾𝑡2 (𝑟𝑖 , αDB) ]2

(4.6)

2
Here, 𝐾𝑚
is the experimentally measured speckle contrast and 𝐾𝑡2 is the

theoretical speckle contrast with assigned αDB calculated using Equation 4.3. In order to
eliminate the influence of the linear scaling factor 𝛽 in Equation 4.3, we normalize both
2
𝐾𝑚
and 𝐾𝑡2 to their mean over all the selected r respectively to cancel 𝛽 from the

calculation (Figure 4.6 (b)) [110].
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In addition to the improvement on quantification of αDB, assessment of 𝜇𝑎 at
multiple wavelengths (λ) would enable the quantification of [Hb] and [HbO2] (see
Chapter 2.2.1).

4.2.8

Phantom tests for simultaneous extraction of µa and αDB
The high sensitivity sCMOS camera (i.e., Orca Flash4.0LT in Table 4.1), which

has better sensitivity in photon sensing, was used in this test.
The pinhole added in the source light path was further optimized for this test to
minimize the influence of the projected laser spot to the diffuse speckle at relatively short
S-D separations, which is critical for the tested algorithm since speckle contrast at short
S-D separations are more sensitive to the change of αDB. There is a trade-off for the
opening of pinhole: the smaller the laser spot is the better signal at short S-D separations;
however, more light is blocked by the pinhole so the signal to noise ratio (SNR)
decreases especially at larger S-D separations. In this study, we optimized the pinhole
opening to get valid data at S-D separations around 3 mm up to around 20 mm. Figure
4.7 shows a comparison of normalized speckle contrast at multiple S-D separations
without (Figure 4.7 (a)) and with (Figure 4.7 (b)) the optimized pinhole in the source
path.
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Figure 4.7 Effect of pinhole optimization.
(a) Before pinhole optimization: the shortest valid source-detector (S-D) separation was
around 10mm. (b) After pinhole optimization: the shortest valid S-D separation was
shorten to around 3mm.
The new algorithm requires input of measured light intensities and speckle
contrasts at multiple S-D separations. At this preliminary stage, our tests were done with
one source located at the center of the FOV (Figure 4.8 (a)). We then optimized the
parameters of the camera and the lens system based on this configuration.
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Figure 4.8 Definition of pixel windows.
(a) Experimental set up for phantom test of the new algorithm. The source location is
fixed at the center of field of view. (b) Pixel window definition in the blue box region
marked in (a): each cluster of pixels with same color is assigned as one pixel window.

A field of view (FOV) of 90 × 90 mm2 was selected to ensure up to 30 mm S-D
separations in all directions. To fulfill the Nyquist sampling criteria that the minimum
speckle size (ρspeckle) must be two times larger than the camera pixel size (ρpixel), the
following equation gives the lower limit of F# [115]:
ρspeckle = 2.44λ (1+M) F# ≥ 2ρpixel

(4.8)

Here, M is the magnification of the imaging system, which is camera sensor size
(i.e., 13.312×13.312 mm2) divided by the size of FOV (90×90mm2). The calculation
results suggest that the minimum F# for the current setting is 6.4.
Several combinations of exposure time (T = 1, 2, 3, 5ms) and F# (6.4, 8, 11) were
tested on tissue like phantoms with varied μ𝑎 levels (0.04 cm-1 to 0.16 cm-1). The
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combination of T = 2ms and F# = 8 gives the best data quality and this is used in the
following tests.
Experimental design for phantom tests. To examine the performance of the
new algorithm, we performed tissue-like liquid phantom tests using the above-mentioned
configuration and parameters (FOV = 90 × 90 mm, T = 2 ms, F# = 8). A glass tank was
filled with the liquid phantom that consisted of distilled water, India ink (Black India,
MA) and Intralipid (Fresenius Kabi, Sweden).
As the new algorithm aimed to extract μ𝑎 and αDB from scDCT data, we varied
μ𝑎 and αDB of the phantom respectively, while μ′𝑠 was set at 10 cm-1 throughout the test.
At each step, 50 frames of images were taken using the scDCT system. For validation,
near infrared spectroscopy (NIRS) and diffuse correlation spectroscopy (DCS)
measurements were also conducted on the tissue phantoms using a hybrid contact probe.
Indian ink titration was done to create gradient in μ𝑎 from 0.04 cm-1 to 0.16 cm-1
with 0.03 cm-1 increment per step, while concentration of intralipid was kept constant
with μ′𝑠 = 10 cm-1 and αDB = ~1 × 10-8 cm2/s. For each titration step, the phantom was
stirred thoroughly and then rested for 2 minutes to allow it to come back to static before
data collection by scDCT and NIRS/DCS.
Changes in Brownian motion (αDB) were created by changing the temperature of
the phantom from 5°C to 25°C (fridge to room temperature). The μ𝑎 and μ′𝑠 were
controlled at 0.1 cm-1 and 10 cm-1 respectively during the flow titration. Data was
collected at each increment of 5°C using scDCT and NIRS/DCS devices. The
temperature was monitored by a thermometer throughout the test and recorded when
optical data were collected.
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For each raw image, dark noise and shot noise were removed before speckle
contrast calculation. Note that, sCMOS camera (i.e., Orca Flash 4.0LT in Table 4.1)
used in this study does not have smear effect as the EMCCD (i.e., Cascade 1K in Table
4.1) had. Spatial speckle contrasts and light intensities in all directions around the source
were calculated in S-D separations ranged from 0.25 to 35 mm, with increment of 0.5
mm. For each S-D separation r0, all pixels within (r0 – 0.2) mm ≤ r ≤ (r0 +0.2) mm were
selected and segmented into pixels windows of 50 adjacent pixels (Figure 4.8 (b)).
Speckle contrasts of each pixel window were calculated using Equation 4.1 and then
averaged over all the pixel windows to get the speckle contrast at r0. Similarly, light
intensities at each S-D separation were calculated and averaged using the same pixel
window assignment for each image. Finally, speckle contrasts and light intensities at
multiple S-D separations were averaged over 50 frames of images for each S-D
separation.
Light intensities at S-D separations of 10 to 20 mm were used to fit μ𝑎 . Speckle
contrasts at S-D separations of 3 to 15 mm were used to fit αDB. For the validating
measurements using NIRS/DCS, μ𝑎 and μ′𝑠 were first calculated from NIRS data at each
step. αDB was then calculated from DCS data with μ𝑎 and μ′𝑠 measured by NIRS as
inputs.
The μ𝑎 and αDB fitted from the new algorithm were compared with NIRS/DCS
measurement results. Percent error in the fitted data with the new algorithm was
calculated by taking NIRS/DCS data as gold standard (i.e., error = 100% × │fitted standard│/standard). Linear regression of μ𝑎 in ink titration was conducted between the
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NIRS data and scDCT data with the new algorithm. Linear regression of αDB was also
conducted between DCS and scDCT measurements.

4.3
4.3.1

Results
Phantom test results
Figure 4.9 (a) shows the cross-section view of the reconstructed flow distribution

at pump speed of 20 ml/min cross the tube anomaly center. The tube shape was clearly
reconstructed. Reconstructed anomaly was determined by a half-maximum threshold and
the reconstructed anomaly flow at each pump speed was calculated as the mean αDB in
the reconstructed anomaly region.

Figure 4.9 The reconstructed 3D images of tube flow contrasts.
(a) Cross section views of x direction at pump speed of 20 ml/min. (b) Linear regression
between the reconstructed percentage flow changes and relative flow changes by the
pump.

For comparison, the reconstructed anomaly flow contrasts were normalized to the
averaged step difference of αDB. The pump speeds were normalized to the step
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difference (i.e., 5 ml/min). Figure 4.9 (b) shows the linear regression between the
reconstructed percentage flow changes and the relative flow changes pumped in the tube.
Perfect linear relationship was observed (y = 0.94x + 8.47, R2 = 0.99, and p < 10−5).
Figure 4.10 (a) illustrates the cross-section views of the reconstructed flow
contrast of the two anomalies in the liquid phantom. Figure 4.10 (b) shows the crosssection views of X-Y plane at different depths (0, 3, 6 and 9 mm) below the phantom
surface. Similarly, the reconstructed anomalies were determined by a half-maximum
threshold. The averaged flow contrasts in the two reconstructed anomalies are 0.32 and
0.25 (relative to a background flow assigning 1). The reconstructed center locations of
the two anomalies are (14.2, 15.4, 24.5 mm) and (-14.4, -15.3, 25.8 mm), which are close
to the designed locations (15.0, 15.0, 25.0 mm) and (-15.0, -15.0, 25.0 mm), respectively.
The reconstructed anomaly diameters are 8.6 and 7.1 mm, which are close to the
diameter of the solid sphere phantoms (∼7 mm).

Figure 4.10 Reconstructed images of spherical phantoms flow contrasts.
(a) Cross section views cross the center of the two spherical anomalies. (b) Cross section
views of X-Y plane at the depths of 0, 3, 6 and 9 mm below the phantom surface.
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4.3.2

Human forearm test results
Figure 4.11 shows the reconstructed 3D forearm BF images during baseline (T1)

(Figure 4.11 (a)), cuff occlusion (T2) (Figure 4.11 (b)), reactive hyperemic peak flow
(T3) (Figure 4.11 (c)), and recovery (T4) (Figure 4.11 (d)). Figure 4.11 (e) shows time
sequence of BF changes relative to resting baseline in the selected two tissue volumes
(marked on Figure 4.11 (a)) of ∼5 mm3 centered at (0, 0, 25 mm) and (16, 16, 25 mm),
respectively. The spatial averaged rBF values inside the two tissue volumes at the four
measurement time points (T1 to T4) shown in Figure 4.11 (e). The rBF trends
throughout the occlusion protocol are consistent in the two selected tissue volumes with
some spatial heterogeneity. The rBF trends and variation level agreed well with previous
results. These results demonstrate the feasibility of scDCT for 3D in vivo imaging of BF
distributions in deep tissue.

Figure 4.11 Reconstructed 3D images of forearm blood flow during cuff occlusion.
Forearm flow images at the periods of baseline (a), cuff occlusion (b), reactive hyperemic
peak flow (c), and recovery (d). (e) Time sequence of flow changes in the selected two
tissue volumes marked in (a).
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4.3.3

3D and 2D imaging of wounds
Two patients with full thickness burn wounds were enrolled in this study [47].

Figure 4.12 shows imaging results from Patient #1. Figure 4.12 (a) shows the surface
color photo of the selected ROI that covers the areas of full thickness burn, partial
thickness burn, and surrounding unburnt tissue. The boundaries across the burn and
unburnt tissues are marked with blue lines. Figure 4.12(b) shows the reconstructed 2D
cross-section views of rBF distributions in the targeted tissue at different depths of 0, 3,
6, and 9 mm below the tissue surface. Each cross-section was averaged from mesh nodes
located within ± 0.2mm range from the center depth. The average rBF values in the full
thickness burn volume, the partial thickness burn volume, and the normal tissue volume
were 0.97 ± 0.054, 1.01 ± 0.053, and 1.04 ± 0.062 (mean ± standard deviation),
respectively (Figure 4.12). One-way ANOVA test revealed significant differences in
rBF among different tissue volumes (p < 0.001). Post-hoc tests in ANOVA suggested
significant differences in rBF for each of pair-wise comparison across different tissue
volumes (p < 0.001). In addition, spatial variations in rBF existed across the ROI and
over different depths. Figure 4.12 (c) shows the 2D mapping of BF distributions which
agreed with the DCT reconstruction results.
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Figure 4.12 BF Distribution in Patient #1.
(a) A photo of the imaged region. (b) 2D cross-section views of relative blood flow (rBF)
distributions at the depths of 0, 3, 6, and 9 mm. (c) 2D mapping of rBF.

Figure 4.13 shows the imaging results from Patient #2. Similarly, significant
lower rBF values (0.92 ± 0.078) were observed in the eschar volume (Figure 4.13),
compared to the surrounding tissue volume (1.06 ± 0.079, p < 0.001, two sample t-test).
Spatial variations in rBF existed across the ROI and over different depths. Note that the
wound in Patient #2 was a burn combined with pressure ulcer, diagnosed during wound
excision. In addition, the range of rBF variation in Patient #2 (0.8 to 1.4) was larger than
that in Patient #1 (0.9 to 1.2). Figure 4.13 (c) shows the 2D mapping of BF distribution;
similar flow pattern was seen as observed in 3D image.

84

Figure 4.13 BF Distribution in Patient #2.
(a) A photo of burn/wound region. (b) 2D cross-section views of relative blood flow
(rBF) distributions at the depths of 0, 3, 6, and 9 mm. (c) 2D mapping of rBF.

4.3.4

Phantom test results for simultaneous extraction of µa and αDB
Results of ink titration and temperature variation are shown in Figure 4.14 and

Figure 4.15. Comparison of μ𝑎 and αDB values obtained from the scDCT with the new
algorithm and from NIRS/DCS are reported in Table 4.2. Linear regressions between
these measurements are shown in Figure 4.16.
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Table 4.2 Summary of phantom test results
𝛍𝐚 (cm-1)

Ink titration
test

Temperature
varying test

𝛂𝐃𝐛 (*10-8 cm2/s)

reference

fitted

Error (%)

reference

fitted

Error (%)

0.040

0.033

15.97

1.08

1.02

5.31

0.073

0.068

6.21

1.22

1.19

3.05

0.100

0.097

3.30

1.28

1.35

5.80

0.127

0.130

2.29

1.10

1.24

13.23

0.155

0.157

1.13

1.11

1.62

45.42

0.099

0.099

0.49

0.77

0.68

11.51

0.099

0.099

0.20

0.80

0.79

1.72

0.099

0.098

0.81

0.90

0.88

2.19

0.099

0.100

0.91

1.00

1.01

0.67

0.099

0.100

1.02

1.17

1.09

7.29

Figure 4.14 Ink titration results.
(a) Comparison results between the fitted absorption coefficient (µa) and NIRS measured
µa. (b) Comparison results between the fitted blood flow index (αDB) and DCS measured
αDB.
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Figure 4.15 Temperature variation results.
(a) Comparison results between the fitted absorption coefficient (µa) and NIRS measured
µa. (b) Comparison results between the fitted αDB and DCS measured αDB.

Figure 4.16 Linear regressions of fitted unknowns against pre-set values.
(a) Linear regression between the fitted µa and NIRS measured µa from ink titration tests.
(b) Linear regression between the fitted blood flow index (αDB) and DCS measured αDB
from temperature variation tests.
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4.4

Discussion and conclusions
We have developed an innovative scDCT system for BF imaging. Use of

EMCCD/sCMOS camera as a 2D detection array significantly increases spatial
resolution and speeds up data acquisition. Comparing to ncDCT that uses APDs as
detector, the motion artifacts and lengthy scan time from mechanical scanning are
mitigated with the novel design of scDCT. The optical zoom lens used in scDCT enabled
adjustment of ROI with different sizes, thus offering translatability of the scDCT for
small animals and large human subjects. The use of galvo mirror enabled flexible
projection of source location to anywhere within FOV and made the source/detector
pattern and scanning density adjustable for different applications.
We have tested the scDCT system using tissue-simulating phantoms with two
types of heterogeneities (high and low flow contrasts relative to the background). In both
cases, flow contrast and anomaly geometries were successfully reconstructed. The
recovered flow contrast changes in the cylindrical tube was highly correlated to the pump
speed changes (R2 = 0.99, and p < 10−5) (Figure 4.9) demonstrating that we accurately
captured the flow contrast/changes using scDCT. The recovered flow contrast of the
solid sphere phantoms were 0.25 and 0.32 to the background (∼1.00) (Figure 4.10),
which are comparable to our previous results found by similar phantoms [39, 44]. Their
localization matched the actual arrangement in the phantom setup. Results from in vivo
imaging on human forearm indicated the capability of scDCT on monitoring deep tissue
blood flow distributions of both temporal and spatial variations. The hyperemic response
after cuff occlusion was clearly visible at multiple locations in the forearm tissue (Figure
4.11). The random spatial variation was expected due to regional tissue heterogeneities.
88

The pilot study on imaging of burn wounds demonstrates the feasibility of scDCT
system for noncontact 3D imaging of blood flow distributions in vulnerable tissues with
no risk of infection. As expected, significant lower BF values were observed in the
burn/wound volumes compared with the surrounding unburn tissue volumes in both
patients. Spatial heterogeneities in rBF were also observed across different tissue
volumes (e.g., partial thickness burn versus full thickness burn) and over different
depths. We noted that the rBF variation in Patient #2 (0.8 to 1.4) was larger than that in
Patient #1 (0.9 to 1.2), generating a better rBF image contrast (Figure 4.13(b)). Thus, the
rBF distribution from Patient #2 (Figure 4.13(b)) matched the pattern of the
wound/eschar (Figure 4.13(a)) better than Patient #1 (Figure 4.12). The relatively
smaller rBF variation/contrast across different tissue areas/volumes in Patient #1 made it
more difficult to be detected. Also, it was possible that the “intact” tissue adjacent to the
wound was affected by adjacent burn. Thus, it was not surprised that lower rBF
areas/volumes were observed in the "intact" tissue adjacent to the "partial thickness
burn" tissue (Figure 4.12). Due to the limited number of subjects in this study (n = 2),
however, it is impossible to test the significance of inter-patient difference in rBF
variations. More subjects are needed to test whether there is a minimum/maximum rBF
variation that limits to clinical utility of the results.
In addition to 3D reconstruction, 2D mapping of BF distributions has been
establishedfor burned wounds. Similar patterns in BF contrasts were obtained comparing
with 3D reconstruction. Comparing to 3D reconstructions which are time consuming
(several hours), the 2D mapping (~3 min) is time efficient. The scDCT provides the
depth resolution with the expense of computation time, whereas 2D mapping provides
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real-time monitoring ability. Comparing to LSCI, 2D mapping with scDCT allows
mapping of BF at different depths by selecting different S-D separations; larger S-D
separations are, more weight from deeper layers. In summary, selection of 2D mapping
and 3D reconstruction should be made upon specific applications.
From the results of imaging burn wounds, although the trends of BF decreases in
burn/wound areas agreed with surgeon’s prediction, the amplitudes of rBF decreases
were smaller than expectated. This may be attributed to the influence of 𝜇𝑎 and 𝜇𝑠 ′ on
αDB calculations, as discussed in Chapter 4.1 and Chapter 4.2.7 [25, 47, 106].
Therefore, we developed the new algorithm for extracting both 𝜇𝑎 and αDB.
The new algorithm extracts μ𝑎 and αDB from the scDCT measurements without
additional instrumentation or measurements. The assessment of 𝜇𝑎 improves the
accuracy of αDB calculation from speckle contrast at multiple S-D separations. In
previous studies, αDB was calculated with assumed 𝜇𝑎 or 𝜇𝑎 measured by other
technique [44, 45, 110]. In this study, we eliminated the need of additional measurement.
Moreover, knowledge of 𝜇𝑎 at multiple wavelengths provides the potential for tissue
oxygenation measurements in the future.
We have validated the new algorithm using tissue-like liquid phantoms with
varied μ𝑎 and αDB. Results measured by the new algorithm agreed well with those
measured by DCS and NIRS over a wide range of 𝜇𝑎 and αDB which are commonly
observed in biological tissues, indicating the potential of the algorithm for calculating
both 𝜇𝑎 and αDB in a variety types of biological tissue. Promising results have been
obtained especially in 𝜇𝑎 using light intensities at multiple S-D separations. Relatively
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larger errors were found in αDB fitting when 𝜇𝑎 was large and SNR was low, indicating
the sensitiveness of the new algorithm to SNRs.
The next step is to apply this new algorithm for in vivo applications. One of the
foreseen challenges is the tissue heterogeneity. Instead of using boundary data over the
full FOV, we may select a subset data at a local/regional area for data fitting to reduce
the influence of tissue heterogeneity. Other work to optimize the algorithm for in vivo
applications include data screening, noise removal, and trade-off between data quality
and time efficiency.
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CHAPTER 5. STUDY SUMMARY, LIMITATIONS, AND FUTURE PERSPECTIVES

5.1

Study Summary and my contributions
In this dissertation, I presented the progression of advancing NIR diffuse optical

techniques for spectroscopic measurements and tomographic imaging of tissue
hemodynamics in vulnerable tissues with the goal of disease diagnosis and treatment
monitoring. For the studies reported in Chapter 2, I participated in the adaptation and
optimization of hybrid near infrared spectroscopy and diffuse correlation spectroscopy
(NIRS/DCS) with a contact fiber-optic probe for simultaneous and continuous
monitoring of absolute values of BF, blood oxygenation, and oxygen consumption in
exercising gastrocnemius [28]. This is the first time that the hybrid NIRS/DCS
techniques together with the novel occlusive calibration and gated dynamometer exercise
protocol have been translated to lower limb measurement. My contributions include
adaptation of the occlusive calibrations for absolute quantification of blood flow (BF)
and oxygen consumption (VO2) in calf muscles, optimization of dynamometer gating
exercise protocols and NIRS/DCS settings, validation tests in young healthy subjects,
and characterization of muscle hemodynamic responses to exercise in older adults with
vitamin D (vitD) insufficiency [38]. I conducted all optical measurements using a hybrid
NIRS/DCS device in older population and analyzed all optical data. I also built an
Arduino-based control system for real-time monitoring and recording of dynamometer
foot pedal position and torque reading. I developed a MATLAB program with graphical
user interface (GUI) for automatic torque peak recognition. Results from these
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measurements indicated that vitD supplement plus aerobic training improved muscle
metabolic function in older population [38].
For the studies reported in Chapter 3, I adapted and optimized an innovative
noncontact diffuse correlation spectroscopy and tomography (ncDCS/ncDCT) system for
three dimensional (3D) imaging of mastectomy skin flaps and chronic wounds [39, 42,
43, 101]. The ncDCS/ncDCT system employed optical lenses to project sources and
detectors remotely onto the tissue surface which is appropriate for vulnerable tissue
assessment comparing with contact apparatus as the noncontact measurement minimized
the risk of inflammation. A motorized linear stage was employed to drive the noncontact
probe to scan over a region of interests (ROI) for 3D tomographic imaging of blood flow
distributions. The ncDCS/ncDCT system was applied in clinical applications, including
intraoperative assessment of blood flow in mastectomy skin flaps [43] and in vivo
imaging of chronic wounds. For intraoperative assessment of mastectomy skin flaps, I
contributed to experimental design, data collection, and result interpretation. We found
that intraoperative relative BF changes (rBF) immediately after mastectomy correlated
with flap viability over months after the surgery, indicating the potential of ncDCS
measurements for predicting skin flap necrosis. For imaging of chronic wounds, I
independently established measurement protocol, performed optical measurements and
data processing. Spatial variations in BF contrasts over the wounded tissues were
observed, indicating the capability of ncDCT in detecting tissue hemodynamic
heterogeneities. The ncDCT holds the potential for longitudinal monitoring and
validation of chronic wound healing.
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For the studies reported in Chapter 4, I adapted and optimized a novel camerabased noncontact speckle contrast DCT (scDCT) for 2D/3D imaging of burn wounds
[44, 45]. The scDCT employed a focused point source and a galvo mirror to remotely
project point light onto source locations over a selected ROI. A camera with a flexible
ROI and fast sampling rate was used for imaging of BF distributions. The camera
provided 2D detector matrix thus eliminated the need for mechanical scanning and
enabled fast data acquisition. Thousands of pixels provided by the camera significantly
improve spatial resolution of imaging. I was involved in building and validating the
scDCT system using tissue-simulating phantoms and in human forearms with a cuff
occlusion protocol [45]. I upgraded the scDCT with a new scientific complementary
metal–oxide–semiconductor (sCMOS) camera and optimized scDCT configuration to
improve data quality. Finally, I adapted the scDCT for 3D imaging of burn wounds. I
independently performed optical measurements and data processing, and wrote the
manuscript [47]. Significantly lower BF values were observed in the burn areas
compared to surrounding normal tissues. Due to the limited subject number, further
interpretation of the measurement and its clinical utility are subject to future work. In
addition to 3D reconstruction, I also explored fast 2D mapping of BF distributions
towards real-time visualization. To overcome the influence of µa on BF quantification, I
developed and validated a new algorithm to extract both µa and αDB using light
intensities and speckle contrasts measured by scDCT at multiple source-detector
distances [105, 106, 109-111]. The new algorithm enabled µa quantification and potential
oxygenation assessment without adding additional measurement and improved the
accuracy of αDB quantification using scDCT. I also designed and conducted phantom

94

validation tests for the new algorithm. In vivo application of the new algorithm is subject
to future work.

5.2

Study limitations and future perspectives
Sample size and measurement validation. The sample sizes in the studies of

imaging chronic wounds (n = 5) and burn wounds (n = 2) were small. In the future, more
patients will be recruited, and results will be compared to other established techniques to
verify the capability of noncontact scDCT for imaging of vulnerable tissues. We may
also recruit and measure more patients with interventions; e.g., peripheral arterial disease
(PAD) patients with ulcers under revascularization and cancer patients undergoing tissue
flap reconstruction. We expect to correlate our measurement results with clinical
outcomes for evaluation and prediction of intervention outcomes.
Accuracy of BF quantification. Current data analyses for scDCT measurements
(i.e., wound imaging) assumed constant 𝜇𝑎 from the literature [47]. This assumption
many result in under- or over-estimation of rBF [25, 106]. Therefore, the new algorithm
for extracting both µa and αDB from scDCT measurements has been developed in this
dissertation work [106, 109, 111]. Future study will translate and optimize this
innovative algorithm for in vivo applications to improve accuracy of BF quantification.
Current scDCT system enables 3D imaging of BF distributions using one single
wavelength. In the future, we may extend to a multi-wavelength system for simultaneous
measurements of BF and oxygenation distributions for comprehensive assessment of
tissue viability.
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Time efficiency of image reconstruction. Depending on mesh density and
boundary configurations, current algorithms for finite element method (FEM) based 3D
image reconstruction requires several hours for computation, which is a big obstacle for
intraoperative real-time monitoring. Recently, a fast and efficient sensitivity map
generation method in NIRFAST for diffuse optical tomography (DOT) reconstruction
has been developed [116]. This method employs a reduced sensitivity matrix and takes
advantage of parallelization processes, thus reducing the computation burden and
shortening the process time significantly. We may adapt this method to the modified
NIRFAST for DCT reconstruction in the future to realize real-time imaging.
Tissue geometry issue. For the patients with wounds imaged by our scDCT [47],
DCT reconstructions were run with the assumption of a flat tissue surface geometry. Our
previous studies showed that irregular tissue surface geometry can influence DCT
reconstructions [46]. Very recently, we integrated a novel photometric stereo technique
into the scDCT system to acquire both tissue surface geometry and boundary BFI data
using the same camera [46]. We will adapt this method in future to improve the quality
of image reconstructions.
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APPENDIX: GLOSSARY
Notations/terms
[Hb]
[HbO2]
μa
µ s’
2D
3D

αDB
APD
ASL-MRI
AT
AUC
BF
CTL
CW
D
DAT
DCS
DCT
DOT
EMCCD
FD
FEM
FOV
fps
GUI
H2O
Hb
HbO2
I
IRB
λ
𝑘0
𝐾
LCD
LDF
MRI
MVC
ncDCS

Descriptions
deoxy-hemoglobin concentration
oxy-hemoglobin concentration
absorption coefficient
reduced scattering coefficient
two dimensional
three dimensional
blood flow index (BFI)
avalanche photodiode
arterial-spin-labeled magnetic resonance imaging
aerobic training
area under the ROC curve
blood flow
control
continuous-wave
vitD repletion alone
vitD repletion + aerobic training
diffuse correlation spectroscopy
diffuse correlation tomography
diffuse optical tomography
electron-multiplying charge coupled device
frequency domain (FD)
finite element method (FEM)
field of view (FOV)
frame per second (fps)
graphical user interface (GUI)
water
deoxy-hemoglobin
oxy-hemoglobin
light intensity
Institutional Review Board (IRB)
wavelength
wavenumber
speckle contrast
liquid crystal display (LCD)
laser Doppler flowmetry (LDF)
magnetic resonance imaging (MRI)
maximal voluntary isometric contractions (MVC)
noncontact diffuse correlation spectroscopy

97

ncDCT
NIR
NIRS
PAD
PET
P-MRS
rBF
ROC
ROI
rVO2
scDCT
sCMOS
SD
S-D
SEM
SNR
StO2
τ
T
T50
THC
UK
vitD
VO2
WCC
ΔStO2

noncontact diffuse correlation tomography
near-infrared light (NIR）
Near-infrared spectroscopy (NIRS)
peripheral arterial disease
Positron emission tomography
phosphorus magnetic resonance spectroscopy
Relative changes in blood flow
receiver operating characteristic
region of interest
relative change in oxygen consumption
speckle contrast DCT
scientific complementary metal–oxide–semiconductor
secure digital
source-detector
standard error of mean
signal-to-noise ratio
blood oxygenation saturation
correlation delay time
Exposure time
recovery half-time
total hemoglobin concentration
University of Kentucky
Vitamin D
oxygen consumption rate
Wound Care Clinic
change of blood oxygenation saturation
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